DXP Enterprises, Inc. Reports First Quarter 2025 Results

DXP Enterprises, Inc. Reports First Quarter 2025 Results

  • $114.3 million in cash
  • $476.6 million in sales, a 15.5 percent year-over-year increase
  • GAAP diluted EPS of $1.25
  • $52.5 million in earnings before interest, taxes, depreciation & amortization and other non-cash charges (“Adjusted EBITDA”)
  • Completed the acquisition of Arroyo Process Equipment

HOUSTON–(BUSINESS WIRE)–DXP Enterprises, Inc. (“DXP” or the “Company”) (NASDAQ: DXPE) today announced financial results for the first quarter ended March 31, 2025. The following are results for the three months ended March 31, 2025, compared to the three months ended March 31, 2024, and December 31, 2024, where appropriate. A reconciliation of the non-GAAP financial measures can be found in the back of this press release.

First Quarter 2025 Financial Highlights:

  • Sales increased 15.5 percent to $476.6 million compared to $412.6 million for the first quarter of 2024 .
  • Net income for the first quarter was $20.6 million, compared to $11.3 million for the first quarter of 2024 and $21.4 million for the fourth quarter of 2024.
  • Earnings per diluted share for the first quarter was $1.25 based upon 16.5 million diluted shares, compared to $0.67 earnings per diluted share in the first quarter of 2024, based on 17.0 million diluted shares. Adjusted diluted earnings per share was $1.26 for the first quarter compared to $0.70 in the first quarter of 2024.
  • Adjusted EBITDA for the first quarter was $52.5 million compared to $40.3 million for the first quarter of 2024 and $50.3 million for the fourth quarter of 2024. Adjusted EBITDA as a percentage of sales, or Adjusted EBITDA margin, was 11.0 percent, 9.8 percent, and 10.7 percent, respectively.

Business segment financial highlights:

  • Service Centers’ revenue for the first quarter was $327.1 million, an increase of 13.4 percent year-over-year, with a 14.4 percent operating income margin.
  • Innovative Pumping Solutions’ revenue for the first quarter was $86.2 million, an increase of 38.5 percent year-over-year, with a 15.6 percent operating income margin.
  • Supply Chain Services’ revenue for the first quarter was $63.3 million, an increase of 2.1 percent year-over-year, with a 8.8 percent operating income margin.

David R. Little, Chairman and Chief Executive Officer commented, “First quarter results reflect the resilience and durability of DXP’s business. We are pleased with our sequential sales growth and strength in our gross profit margins. This resulted in operating leverage that produced earnings per share of $1.25. DXP’s first quarter 2025 sales were $476.6 million, or a 15.5 percent increase over the first quarter of 2024. Organic sales for the quarter, increased 11.1 percent and acquisitions added $31.1 million in sales. Adjusted EBITDA grew $12.2 million, or 30.2 percent over the first quarter of 2024. During the first quarter of 2025, sales were $327.1 million for Service Centers, $63.3 million for Supply Chain Services, and $86.2 million for Innovative Pumping Solutions. Overall, we are very pleased with our performance and the progress DXP continues to make as a growth company. We are optimistic that we can show continued sales and profit improvement during the remainder of 2025.”

Kent Yee, Chief Financial Officer and Senior Vice President, remarked, “Our first quarter year-over-year increase of 15.5 percent was great to see. We continue to see bright spots in the market, and we currently anticipate the second half of the year to drive growth as we benefit from increases in our project backlog and the diversification of our end markets. DXP ended the quarter with $114.3 million in cash on the balance sheet. Specifically, this quarter reflects continued execution of our strategic goals and the confidence we have in our balanced mix of business, tremendous teams, and a strong balance sheet to support our key initiatives. Total debt outstanding as of March 31, 2025, was $647.3 million. DXP’s secured leverage ratio or net debt to EBITDA ratio was 2.50:1.0 with a covenant EBITDA of $212.8 million for the last twelve months ending March 31, 2025.”

Conference Call Information

DXP Enterprises, Inc. management will host a conference call, May 8, 2025, at 10:30 a.m. Central Time, to discuss the Company’s financial results. The conference call may be accessed by going to https://ir.dxpe.com.

Interested investors and other parties can listen to a webcast of the live conference call by logging onto the Investor Relations section of the Company’s website at https://ir.dxpe.com. The online replay will be available on the same website immediately following the call. A slide presentation highlighting the Company’s results and key performance indicators will also be available on the Investor Relations section of the Company’s website.

To learn more about DXP Enterprises, Inc., please visit the Company’s website at https://www.dxpe.com

About DXP Enterprises, Inc.

DXP Enterprises, Inc. is a leading products and service distributor that adds value and total cost savings solutions to industrial customers throughout North America and Dubai. DXP provides innovative pumping solutions, supply chain services and maintenance, repair, operating and production (“MROP”) services that emphasize and utilize DXP’s vast product knowledge and technical expertise in rotating equipment, bearings, power transmission, metal working, industrial supplies and safety products and services. DXP’s breadth of MROP products and service solutions allows DXP to be flexible and customer-driven, creating competitive advantages for our customers. DXP’s business segments include Service Centers, Innovative Pumping Solutions and Supply Chain Services. For more information, go to www.dxpe.com.

Non-GAAP Financial Measures

DXP supplements reporting of net income with certain non-GAAP measurements, including EBITDA, Adjusted EBITDA, EBITDA Margin, Adjusted EBITDA Margin, and Free Cash Flow. This supplemental information should not be considered in isolation or as a substitute for the unaudited GAAP measurements. Additional information regarding EBITDA, Adjusted EBITDA, EBITDA Margin, Adjusted EBITDA Margin, Free Cash Flow and net debt referred to in this press release are included below under “Unaudited Reconciliation of Non-GAAP Financial Information”.

The Company believes EBITDA provides additional information about: (i) operating performance, because it assists in comparing the operating performance of the business, as it removes the impact of non-cash depreciation and amortization expense as well as items not directly resulting from core operations such as interest expense and income taxes and (ii) the performance and the effectiveness of operational strategies. Additionally, EBITDA performance is a component of a measure of the Company’s financial covenants under its credit facilities. Furthermore, some investors use EBITDA as a supplemental measure to evaluate the overall operating performance of companies in the industry. Management believes that some investors’ understanding of performance is enhanced by including this non-GAAP financial measure as a reasonable basis for comparing ongoing results of operations. By providing this non-GAAP financial measure, together with a reconciliation to its most directly comparable GAAP financial measure, the Company believes it is enhancing investors’ understanding of the business and results of operations, as well as assisting investors in evaluating how well the Company is executing strategic initiatives. Free Cash Flow reconciles to the most directly comparable GAAP financial measure of cash flows from operations as provided below. We believe Free Cash Flow is an important liquidity metric because it measures, during a given period, the amount of cash generated that is available to fund acquisitions, make investments, repay debt obligations, repurchase shares of the Company’s common stock, and for certain other activities.

Information Related to Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 provides a “safe-harbor” for forward-looking statements. Certain information included in this press release (as well as information included in oral statements or other written statements made by or to be made by the Company) contains statements that are forward-looking. These forward-looking statements include, without limitation, those about the Company’s expectations regarding the Company’s expectations regarding the filing of the Form 10-Q; the description of the anticipated changes in the Company’s consolidated balance sheet and the results of operations and the Company’s assessment of the impact of such anticipated changes; the Company’s business, the Company’s future profitability, cash flow, liquidity, and growth. Such forward-looking information involves important risks and uncertainties that could significantly affect anticipated results in the future; and accordingly, such results may differ from those expressed in any forward-looking statement made by or on behalf of the Company. These risks and uncertainties include, but are not limited to: the effectiveness of management’s strategies and decisions; our ability to implement our internal growth and acquisition growth strategies; general economic and business conditions specific to our primary customers; changes in government regulations; our ability to effectively integrate businesses we may acquire; new or modified statutory or regulatory requirements; availability of materials and labor; inability to obtain or delay in obtaining government or third-party approvals and permits; non-performance by third parties of their contractual obligations; unforeseen hazards such as weather conditions, acts of war or terrorist acts and the governmental or military response thereto; cyber-attacks adversely affecting our operations; other geological, operating and economic considerations and declining prices and market conditions, including supply or demand for maintenance, repair and operating products, equipment and service; inability of the Company or its independent auditors to complete the work necessary in order to file the Form 10-Q in the expected time frame; unanticipated changes to the Company’s operating results in the Form 10-Q as filed or in relation to prior periods, including as compared to the anticipated changes stated here; unanticipated impact of such changes and its materiality; ability to obtain needed capital, dependence on existing management, leverage and debt service, domestic or global economic conditions, ability to manage changes and the continued health or availability of management personnel and changes in customer preferences and attitudes. In some cases, you can identify forward-looking statements by terminology such as, but not limited to, “may,” “will,” “should,” “intend,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “goal,” or “continue” or the negative of such terms or other comparable terminology. More information on these risks and other potential factors that could affect the Company’s business and financial results is included in the Company’s filings with the Securities and Exchange Commission, including in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of the Company’s most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.

DXP ENTERPRISES, INC. AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

($ thousands, except share amounts)

 

 

Three Months Ended March 31,

 

 

2025

 

 

 

2024

 

 

 

 

 

Sales

$

476,569

 

 

$

412,635

 

Cost of sales

 

326,304

 

 

 

288,753

 

Gross profit

 

150,265

 

 

 

123,882

 

Selling, general and administrative expenses

 

109,750

 

 

 

94,751

 

Income from operations

 

40,515

 

 

 

29,131

 

Interest expense

 

14,660

 

 

 

15,544

 

Other income, net

 

(1,318

)

 

 

(1,968

)

Income before income taxes

 

27,173

 

 

 

15,555

 

Provision for income taxes

 

6,584

 

 

 

4,223

 

Net income

 

20,589

 

 

 

11,332

 

Preferred stock dividend

 

23

 

 

 

23

 

Net income attributable to common shareholders

$

20,566

 

 

$

11,309

 

 

 

 

 

Net income

$

20,589

 

 

$

11,332

 

Foreign currency translation adjustments

 

86

 

 

 

(614

)

Comprehensive income

$

20,675

 

 

$

10,718

 

 

 

 

 

Earnings per share:

 

 

 

Basic

$

1.31

 

 

$

0.70

 

Diluted

$

1.25

 

 

$

0.67

 

 

 

 

 

Weighted average common shares outstanding:

 

 

 

Basic

 

15,698

 

 

 

16,128

 

Diluted

 

16,538

 

 

 

16,968

 

DXP ENTERPRISES, INC. AND SUBSIDIARIES

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

($ thousands, except share amounts)

 

 

March 31, 2025

 

December 31, 2024

ASSETS

 

 

 

Current assets:

 

 

 

Cash

$

114,283

 

 

$

148,320

 

Restricted cash

 

 

 

 

91

 

Accounts receivable, net of allowance of $3,537 and $5,172, respectively

 

357,764

 

 

 

339,365

 

Inventories

 

109,876

 

 

 

103,113

 

Costs and estimated profits in excess of billings

 

47,844

 

 

 

50,735

 

Prepaid expenses and other current assets

 

31,989

 

 

 

20,250

 

Total current assets

 

661,756

 

 

 

661,874

 

Property and equipment, net

 

97,658

 

 

 

81,556

 

Goodwill

 

459,963

 

 

 

452,343

 

Other intangible assets, net

 

83,608

 

 

 

85,679

 

Operating lease right of use assets, net

 

59,597

 

 

 

46,569

 

Other long-term assets

 

19,930

 

 

 

21,473

 

Total assets

$

1,382,512

 

 

$

1,349,494

 

 

 

 

 

LIABILITIES AND EQUITY

 

 

 

Current liabilities:

 

 

 

Current maturities of debt

$

6,595

 

 

$

6,595

 

Trade accounts payable

 

114,301

 

 

 

103,728

 

Accrued wages and benefits

 

39,334

 

 

 

41,650

 

Customer advances

 

13,477

 

 

 

13,655

 

Billings in excess of costs and estimated profits

 

19,779

 

 

 

12,662

 

Short-term operating lease liabilities

 

16,608

 

 

 

14,921

 

Other current liabilities

 

35,323

 

 

 

50,773

 

Total current liabilities

 

245,417

 

 

 

243,984

 

Long-term debt, net of unamortized debt issuance costs and discounts

 

620,901

 

 

 

621,684

 

Long-term operating lease liabilities

 

44,583

 

 

 

33,159

 

Other long-term liabilities

 

26,952

 

 

 

27,879

 

Total long-term liabilities

 

692,436

 

 

 

682,722

 

Total liabilities

 

937,853

 

 

 

926,706

 

Commitments and Contingencies

 

 

 

Shareholders’ equity:

 

 

 

Series A preferred stock, $1.00 par value; 1,000,000 shares authorized

 

1

 

 

 

1

 

Series B preferred stock, $1.00 par value; 1,000,000 shares authorized

 

15

 

 

 

15

 

Common stock, $0.01 par value, 100,000,000 shares authorized; 20,402,063 issued and 15,694,290 outstanding at March 31, 2025 and 20,402,861 issued and 15,695,088 outstanding at December 31, 2024

 

204

 

 

 

204

 

Additional paid-in capital

 

220,702

 

 

 

219,511

 

Retained earnings

 

410,236

 

 

 

389,670

 

Accumulated other comprehensive loss

 

(33,524

)

 

 

(33,610

)

Treasury stock, at cost 4,707,773 and 4,707,773 shares, respectively

 

(152,975

)

 

 

(153,003

)

Total DXP Enterprises, Inc. equity

 

444,659

 

 

 

422,788

 

Total liabilities and equity

$

1,382,512

 

 

$

1,349,494

 

SEGMENT DATA

($ thousands, unaudited)

 

 

Three Months Ended March 31,

Sales

 

2025

 

 

2024

Service Centers

$

327,075

 

$

288,435

Innovative Pumping Solutions

 

86,182

 

 

62,216

Supply Chain Services

 

63,312

 

 

61,984

Total Sales

$

476,569

 

$

412,635

 

 

 

 

 

 

 

 

 

Three Months Ended March 31,

Operating Income

 

2025

 

 

2024

Service Centers

$

47,045

 

$

40,320

Innovative Pumping Solutions

 

13,406

 

 

6,970

Supply Chain Services

 

5,564

 

 

5,262

Total Segments Operating Income

$

66,015

 

$

52,552

RECONCILIATION OF OPERATING INCOME FOR REPORTABLE SEGMENTS

($ thousands, unaudited)

 

 

 

 

 

Three Months Ended March 31,

 

 

2025

 

 

 

2024

 

Income from operations for reportable segments

$

66,015

 

 

$

52,552

 

Adjustment for:

 

 

 

Amortization of intangibles

 

5,355

 

 

 

4,369

 

Corporate expenses

 

20,145

 

 

 

19,052

 

Income from operations

$

40,515

 

 

$

29,131

 

Interest expense

 

14,660

 

 

 

15,544

 

Other income, net

 

(1,318

)

 

 

(1,968

)

Income before income taxes

$

27,173

 

 

$

15,555

 

RECONCILIATION OF NON-GAAP FINANCIAL INFORMATION

($ thousands, unaudited)

 

We define and calculate EBITDA as Net income attributable to DXP Enterprises, Inc., plus interest, taxes, depreciation, and amortization. We define and calculate Adjusted EBITDA as Net income attributable to DXP Enterprises, Inc., plus interest, taxes, depreciation, and amortization minus stock-based compensation expense and all other non-cash charges, adjustments, and non-recurring items. We identify the impact of all other non-cash charges, adjustments and non-recurring items because we believe these items do not directly reflect our underlying operations.

 

We define and calculate EBITDA Margin as EBITDA divided by sales. We define and calculate Adjusted EBITDA Margin as Adjusted EBITDA divided by sales.

 

The following table sets forth the reconciliation of EBITDA, EBITDA Margin, Adjusted EBITDA and Adjusted EBITDA Margin to the most comparable U.S. GAAP financial measure (in thousands):

 

 

Three Months Ended March 31,

 

 

2025

 

 

 

2024

 

Income before income taxes

$

27,173

 

 

$

15,555

 

Plus: Interest expense

 

14,660

 

 

 

15,544

 

Plus: Depreciation and amortization

 

9,134

 

 

 

7,538

 

EBITDA

$

50,967

 

 

$

38,637

 

Plus: other non-recurring items(1)

 

235

 

 

 

842

 

Plus: stock compensation expense

 

1,317

 

 

 

864

 

Adjusted EBITDA

$

52,519

 

 

$

40,343

 

 

 

 

 

Operating Income Margin

 

8.5

%

 

 

7.1

%

EBITDA Margin

 

10.7

%

 

 

9.4

%

Adjusted EBITDA Margin

 

11.0

%

 

 

9.8

%

(1) Other non-recurring items includes unique acquisition integration costs and other non-cash, non-recurring costs not related to continuing business operations.

 

We define and calculate organic sales to include locations and acquisitions under our ownership for at least twelve months. “Acquisition Sales” are sales from acquisitions that have been under our ownership for less than twelve months and are excluded in our calculation of Organic Sales. 

The following table sets forth the reconciliation of Acquisition Sales, Organic Sales and Organic Sales per Business Day to the most comparable U.S. GAAP financial measure (in thousands):

 

 

Three Months Ended March 31,

 

 

2025

 

 

2024

Sales by Business Segment

 

 

 

Service Centers

$

327,075

 

$

288,435

Innovative Pumping Solutions

 

86,182

 

 

62,216

Supply Chain Services

 

63,312

 

 

61,984

Total DXP Sales

$

476,569

 

$

412,635

Acquisition Sales

$

31,112

 

$

11,775

Organic Sales

$

445,457

 

$

400,860

 

 

 

 

Business Days

 

63

 

 

63

Sales per Business Day

$

7,565

 

$

6,550

Organic Sales per Business Day

$

7,071

 

$

6,363

 

We define and calculate free cash flow as net cash (used in) provided by operating activities less purchases of property and equipment.

The following table sets forth the reconciliation of Free Cash Flow to the most comparable GAAP financial measure (in thousands):

 

 

Three Months Ended March 31,

 

 

2025

 

 

 

2024

 

Net cash from operating activities

$

2,973

 

 

$

26,989

 

Less: purchases of property and equipment

 

(19,914

)

 

 

(2,894

)

Free Cash Flow

$

(16,941

)

 

$

24,095

 

 

We define and calculate adjusted net income as Net income plus non-recurring items less adjustment for taxes.

The following table is a reconciliation of adjusted net income attributable to DXP Enterprises, Inc., a non-GAAP financial measure, to net income, calculated and reported in accordance with U.S. GAAP (in thousands).

 

 

Three Months Ended March 31,

 

 

2025

 

 

 

2024

 

Net Income

$

20,589

 

 

$

11,332

 

Other non-recurring items

 

235

 

 

 

842

 

Adjustment for taxes

 

(57

)

 

 

(256

)

Adjusted Net Income

$

20,767

 

 

$

11,918

 

 

 

 

 

Weighted average common shares and common equivalent shares outstanding

 

 

 

Diluted

 

16,538

 

 

 

16,968

 

 

 

 

 

Diluted Earnings per Share

$

1.25

 

 

$

0.67

 

Adjusted Diluted Earnings per Share

$

1.26

 

 

$

0.70

 

 

Kent Yee

Senior Vice President, CFO

713-996-4700

www.dxpe.com

KEYWORDS: United States North America Canada Texas

INDUSTRY KEYWORDS: Other Transport Manufacturing Transport Food Tech Logistics/Supply Chain Management Technology Other Energy Mining/Minerals Utilities Forest Products Oil/Gas Coal Agriculture Alternative Energy Natural Resources Energy Nuclear Chemicals/Plastics

MEDIA:

Logo
Logo

Trinseo Reports First Quarter 2025 Financial Results and Provides Second Quarter Outlook

Trinseo Reports First Quarter 2025 Financial Results and Provides Second Quarter Outlook

First Quarter 2025 Highlights

  • Net loss of $79 million and EPS of negative $2.22 included $25 million of refinancing costs for the debt transactions that closed in January 2025
  • Adjusted EBITDA* of $65 million was $20 million above prior year driven by $26 million of polycarbonate technology licensing income as well as savings from the previously announced restructuring actions; partially offset by lower equity income from Americas Styrenics and lower volumes
  • Cash used in operations of $110 million and capital expenditures of $9 million resulted in Free Cash Flow* of negative $119 million, which included a seasonal working capital build and $25 million of refinancing-related costs
  • First quarter ending cash of $128 million (of which $2 million was restricted) and total liquidity of $421 million

WAYNE, Pa.–(BUSINESS WIRE)–
Trinseo (NYSE: TSE):

 

 

Three Months Ended

 

 

March 31,

$millions, except per share data

 

2025

 

2024

Net Sales

 

$

785

 

 

$

904

 

Net Loss

 

 

(79

)

 

 

(76

)

Diluted EPS ($)

 

 

(2.22

)

 

 

(2.14

)

Adjusted Net Loss*

 

 

(49

)

 

 

(69

)

Adjusted EPS ($)*

 

 

(1.37

)

 

 

(1.94

)

EBITDA*

 

 

30

 

 

 

38

 

Adjusted EBITDA*

 

 

65

 

 

 

45

 

*For a reconciliation of EBITDA, Adjusted EBITDA, and Adjusted Net Loss, all of which are non-GAAP measures, to Net Loss, as well as a reconciliation of Free Cash Flow and Adjusted EPS, see Notes 2 and 3 to the financial statements included below.

Trinseo (NYSE: TSE), a specialty material solutions provider, today reported its first quarter 2025 financial results. Net sales of $785 million in the first quarter decreased 13% versus prior year from lower sales volume across all business segments due to continued end market demand weakness and intentional reductions of low-margin sales. Higher prices, primarily from the pass-through of higher raw material costs and improved product mix, led to a 2% increase which was offset by a 2% decrease from currency.

First quarter net loss of $79 million was $3 million higher than prior year primarily due to higher interest expense and a slightly higher provision for income taxes. Adjusted EBITDA of $65 million was $20 million above prior year driven by $26 million of polycarbonate technology licensing income as well as savings from the previously announced restructuring actions. These were partially offset by lower volumes as well as lower income from Americas Styrenics.

Commenting on the Company’s first quarter performance, Frank Bozich, President and Chief Executive Officer of Trinseo, said, “Core business results in the first quarter were in line with expectations, and sequentially higher due to prior quarter customer destocking and seasonality. Despite persistent market weakness, the first quarter was Trinseo’s 7th consecutive quarter of year-over-year Adjusted EBITDA improvement driven by the various management actions we took early in this industry downturn.”

First Quarter Results and Commentary by Business Segment

  • Engineered Materials net sales of $278 million for the quarter were 2% below prior year as lower sales volume was partially offset by higher pricing. Adjusted EBITDA of $26 million was $16 million above prior year, reflecting higher margins from moderating input costs. Sales volume growth in consumer electronics applications and from our geographic expansion initiatives for PMMA were offset by lower market demand in automotive and building and construction.
  • Latex Binders net sales of $209 million for the quarter decreased 13% versus prior year from lower volumes, primarily in paper applications in Asia and Europe, which were partially offset by higher price. Adjusted EBITDA of $24 million was $2 million below prior year due to lower volume. Net sales to CASE applications accounted for 15% of total segment net sales with volume increasing 3% over prior year in a flat market environment.
  • Polymer Solutions net sales of $298 million for the quarter decreased 22% versus prior year due to lower sales volume, which was primarily the result of intentionally reducing low-margin polystyrene sales. Adjusted EBITDA of $44 million was $15 million above prior year, as lower volumes and margins were more than offset by fixed cost reductions and $26 million of polycarbonate technology licensing income.
  • Americas Styrenics Adjusted EBITDA of negative $2 million for the quarter was $8 million below prior year mainly driven by an unfavorable timing impact.

Second Quarter 2025 Outlook

  • Second quarter 2025 net loss of $61 million to $46 million
  • Second quarter 2025 Adjusted EBITDA of $55 million to $70 million
  • Second quarter 2025 Free Cash Flow approximately breakeven and includes $21 million from the polycarbonate technology license income collected in the second quarter

We expect the direct impact from current tariffs to be limited, as we generally manufacture products and procure raw materials in the regions where our products are sold. However, the high level of macroeconomic uncertainty that currently exists limits our ability to assess future end-market demand. Therefore, we are withdrawing all full-year guidance previously furnished in connection with our recent debt refinancing and will focus only on second quarter guidance.

Commenting on the second quarter outlook, Bozich said, “We anticipate Adjusted EBITDA of $55 million to $70 million in Q2 with seasonally higher volumes, lower costs in Engineered Materials, and improved AmSty performance offsetting the first quarter polycarbonate technology license income. I am extremely proud of the agility and resourcefulness demonstrated by all of our employees as we navigate this challenging market environment.

Conference Call and Webcast Information

Trinseo will host a conference call to discuss its first quarter 2025 financial results on Thursday, May 8, 2025 at 10 a.m. Eastern Time.

Commenting on results will be Frank Bozich, President and Chief Executive Officer, David Stasse, Executive Vice President and Chief Financial Officer, and Bee van Kessel, Senior Vice President, Corporate Finance and Investor Relations.

For those interested in asking questions during the Q&A session, please register using the following link:

For those interested in listening only, please register for the webcast using the following link:

After registering for the conference call, you will receive a confirmation email with a meeting invitation and information for entry. Registration is open through the live call, but it is advised that you register in advance to ensure you are connected for the full call.

Trinseo has posted its first quarter 2025 financial results on the Company’s Investor Relations website. The presentation slides will also be made available in the webcast player prior to the conference call. The Company will also furnish copies of the financial results press release and presentation slides to investors by means of a Form 8-K filing with the U.S. Securities and Exchange Commission.

A replay of the conference call and transcript will be archived on the Company’s Investor Relations website shortly following the conference call. The replay will be available until May 8, 2026.

About Trinseo

Trinseo (NYSE: TSE), a specialty material solutions provider, partners with companies to bring ideas to life in an imaginative, smart and sustainably focused manner by combining its premier expertise, forward-looking innovations and best-in-class materials to unlock value for companies and consumers.

From design to manufacturing, Trinseo taps into decades of experience in diverse material solutions to address customers’ unique challenges in a wide range of industries, including building and construction, consumer goods, medical and mobility.

Trinseo’s employees bring endless creativity to reimagining the possibilities with clients all over the world from the company’s locations in North America, Europe and Asia Pacific. Trinseo reported net sales of approximately $3.5 billion in 2024. Discover more by visiting www.trinseo.com and connecting with Trinseo on LinkedIn, Twitter, Facebook.

Use of non-GAAP measures

In addition to using standard measures of performance and liquidity that are recognized in accordance with accounting principles generally accepted in the United States of America (“GAAP”), we use additional measures of income excluding certain GAAP items (“non-GAAP measures”), such as Adjusted Net Income, EBITDA, Adjusted EBITDA and Adjusted EPS and measures of liquidity excluding certain GAAP items, such as Free Cash Flow. We believe these measures are useful for investors and management in evaluating business trends and performance each period. These measures are also used to manage our business and assess current period profitability, as well as to provide an appropriate basis to evaluate the effectiveness of our pricing strategies. Such measures are not recognized in accordance with GAAP and should not be viewed as an alternative to GAAP measures of performance or liquidity, as applicable. The definitions of each of these measures, further discussion of usefulness, and reconciliations of non-GAAP measures to GAAP measures are provided in the Notes to Condensed Consolidated Financial Information presented herein.

Cautionary Note on Forward-Looking Statements

This press release may contain forward-looking statements including, without limitation, statements concerning plans, objectives, goals, projections, forecasts, strategies, future events or performance, and underlying assumptions and other statements, which are not statements of historical facts or guarantees or assurances of future performance. Forward-looking statements may be identified by the use of words like “expect,” “anticipate,” “believe,” “intend,” “forecast,” ”estimate,” “see,” “outlook,” “will,” “may,” “might,” “potential,” “likely,” “target,” “plan,” “contemplate,” “seek,” “attempt,” “should,” “could,” “would,” or expressions of similar meaning. Forward-looking statements reflect management’s evaluation of information currently available and are based on our current expectations and assumptions regarding our business, the economy, our current indebtedness, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Factors that might cause future results to differ from those expressed by the forward-looking statements include, but are not limited to, conditions in the global economy and capital markets, including recessionary conditions and the impact of tariffs on global trade relations; our ability to successfully generate cost savings through restructuring and cost reduction initiatives; our ability to successfully execute our business and transformation strategy; increased costs or disruption in the supply of raw materials; deterioration of our credit profile limiting our access to commercial credit; increased energy costs; the timing of, and our ability to complete, a sale of our interest in Americas Styrenics; compliance with laws and regulations impacting our business; any disruptions in production at our chemical manufacturing facilities, including those resulting from accidental spills or discharges; our current and future levels of indebtedness and our ability to service, repay or refinance our indebtedness; our ability to meet the covenants under our existing indebtedness; our ability to generate cash flows from operations and achieve our forecasted cash flows; and those discussed in our Annual Report on Form 10-K, under Part I, Item 1A —”Risk Factors” and elsewhere in our other reports, filings and furnishings made with the U.S. Securities and Exchange Commission from time to time. As a result of these or other factors, our actual results, performance or achievements may differ materially from those contemplated by the forward-looking statements. Therefore, we caution you against relying on any of these forward-looking statements. The forward-looking statements included in this press release are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

 

TRINSEO PLC

 

Condensed Consolidated Statements of Operations

(In millions, except per share data)

(Unaudited)

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2025

 

2024

 

Net sales

 

$

784.8

 

 

$

904.0

 

 

Cost of sales

 

 

721.0

 

 

 

843.4

 

 

Gross profit

 

 

63.8

 

 

 

60.6

 

 

Selling, general and administrative expenses

 

 

91.0

 

 

 

70.1

 

 

Equity in earnings (losses) of unconsolidated affiliate

 

 

(1.8

)

 

 

6.2

 

 

Operating loss

 

 

(29.0

)

 

 

(3.3

)

 

Interest expense, net

 

 

66.6

 

 

 

63.0

 

 

Other expense (income), net

 

 

(23.2

)

 

 

3.8

 

 

Loss before income taxes

 

 

(72.4

)

 

 

(70.1

)

 

Provision for income taxes

 

 

6.6

 

 

 

5.4

 

 

Net loss

 

$

(79.0

)

 

$

(75.5

)

 

Weighted average shares- basic

 

 

35.5

 

 

 

35.3

 

 

Net loss per share- basic

 

$

(2.22

)

 

$

(2.14

)

 

Weighted average shares- diluted

 

 

35.5

 

 

 

35.3

 

 

Net loss per share- diluted

 

$

(2.22

)

 

$

(2.14

)

 

 

TRINSEO PLC

 

Condensed Consolidated Balance Sheets

(In millions)

(Unaudited)

 

 

 

 

 

 

 

 

 

March 31,

 

December 31,

 

 

2025

 

2024

Assets

 

 

 

 

 

 

Cash and cash equivalents

 

$

126.1

 

 

$

209.8

 

Accounts receivable, net of allowance

 

 

470.5

 

 

 

379.9

 

Inventories

 

 

383.7

 

 

 

347.2

 

Other current assets

 

 

55.7

 

 

 

51.3

 

Investments in unconsolidated affiliate

 

 

220.8

 

 

 

222.6

 

Property, plant, equipment, goodwill, and other intangible assets, net

 

 

1,218.6

 

 

 

1,234.5

 

Right-of-use assets – operating, net

 

 

62.6

 

 

 

63.9

 

Other long-term assets

 

 

117.0

 

 

 

134.9

 

Total assets

 

$

2,655.0

 

 

$

2,644.1

 

Liabilities and shareholders’ equity

 

 

 

 

 

 

Current liabilities

 

 

689.3

 

 

 

720.9

 

Long-term debt, net of unamortized deferred financing fees

 

 

2,305.1

 

 

 

2,200.7

 

Noncurrent lease liabilities – operating

 

 

52.7

 

 

 

53.3

 

Other noncurrent obligations

 

 

287.1

 

 

 

289.1

 

Shareholders’ equity (deficit)

 

 

(679.2

)

 

 

(619.9

)

Total liabilities and shareholders’ equity (deficit)

 

$

2,655.0

 

 

$

2,644.1

 

 

TRINSEO PLC

 

Condensed Consolidated Statements of Cash Flows

(In millions)

(Unaudited)

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

March 31,

 

 

2025

 

2024

Cash flows from operating activities

 

 

 

 

 

 

Cash used in operating activities

 

$

(110.2

)

 

$

(66.2

)

 

 

 

 

 

 

 

Cash flows from investing activities

 

 

 

 

 

 

Capital expenditures

 

 

(8.7

)

 

 

(15.7

)

Proceeds from the sale of businesses and other assets

 

 

 

 

 

4.7

 

Cash used in investing activities

 

 

(8.7

)

 

 

(11.0

)

 

 

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

 

 

Deferred financing fees

 

 

(19.8

)

 

 

0.4

 

Short-term borrowings, net

 

 

(1.8

)

 

 

(3.7

)

Dividends paid

 

 

(0.5

)

 

 

(0.6

)

Acquisition-related contingent consideration payment

 

 

 

 

 

(0.7

)

Net proceeds from issuance of 2028 Refinance Term Loans

 

 

115.0

 

 

 

 

Repurchases and repayments of long-term debt

 

 

(5.1

)

 

 

(4.6

)

Repayments of 2025 Senior Notes

 

 

(115.0

)

 

 

 

Proceeds from Accounts Receivable Securitization Facility

 

 

70.0

 

 

 

30.0

 

Repayments of Accounts Receivable Securitization Facility

 

 

(10.0

)

 

 

(30.0

)

Cash provided by (used in) financing activities

 

 

32.8

 

 

 

(9.2

)

Effect of exchange rates on cash

 

 

2.5

 

 

 

(3.2

)

Net change in cash, cash equivalents, and restricted cash

 

 

(83.6

)

 

 

(89.6

)

Cash, cash equivalents, and restricted cash—beginning of period

 

 

211.9

 

 

 

261.1

 

Cash, cash equivalents, and restricted cash—end of period

 

$

128.3

 

 

$

171.5

 

Less: Restricted cash

 

 

2.2

 

 

 

5.1

 

Cash and cash equivalents—end of period

 

$

126.1

 

 

$

166.4

 

 

TRINSEO PLC

Notes to Condensed Consolidated Financial Information

(Unaudited)

Note 1: Net Sales by Segment

 

 

Three Months Ended

 

 

March 31,

(In millions)

 

2025

 

2024

Engineered Materials

 

$

277.3

 

$

282.5

Latex Binders

 

 

209.3

 

 

241.5

Polymer Solutions

 

 

298.2

 

 

380.0

Americas Styrenics*

 

 

 

 

Total Net Sales

 

$

784.8

 

$

904.0

* The results of this segment are comprised entirely of earnings from Americas Styrenics, our 50%-owned equity method investment. As such, we do not separately report net sales of Americas Styrenics within our condensed consolidated statements of operations.

Note 2: Reconciliation of Non-GAAP Performance Measures to Net Income

EBITDA is a non-GAAP financial performance measure, which is defined as income from continuing operations before interest expense, net; income tax provision; depreciation and amortization expense. We refer to EBITDA in making operating decisions because we believe it provides our management as well as our investors with meaningful information regarding the Company’s operational performance. We believe the use of EBITDA as a metric assists our board of directors, management and investors in comparing our operating performance on a consistent basis.

We also present Adjusted EBITDA as a non-GAAP financial performance measure, which we define as income from continuing operations before interest expense, net; income tax provision; depreciation and amortization expense; loss on extinguishment of long-term debt; asset impairment charges; gains or losses on the dispositions of businesses and assets; restructuring charges; acquisition related costs and benefits, and other items. In doing so, we are providing management, investors, and credit rating agencies with an indicator of our ongoing performance and business trends, removing the impact of transactions and events that we would not consider a part of our core operations.

Lastly, we present Adjusted Net Income (Loss) and Adjusted EPS as additional performance measures. Adjusted Net Income (Loss) is calculated as Adjusted EBITDA (defined beginning with net income from continuing operations, above), less interest expense, less the provision for income taxes and depreciation and amortization, tax affected for various discrete items, as appropriate. Adjusted EPS is calculated as Adjusted Net Income (Loss) per weighted average diluted shares outstanding for a given period. We believe that Adjusted Net Income (Loss) and Adjusted EPS provide transparent and useful information to management, investors, analysts and other stakeholders in evaluating and assessing our operating results from period-to-period after removing the impact of certain transactions and activities that affect comparability and that are not considered part of our core operations.

There are limitations to using the financial performance measures noted above. These performance measures are not intended to represent net income or other measures of financial performance. As such, they should not be used as alternatives to net income as indicators of operating performance. Other companies in our industry may define these performance measures differently than we do. As a result, it may be difficult to use these or similarly named financial measures that other companies may use, to compare the performance of those companies to our performance. We compensate for these limitations by providing reconciliations of these performance measures to our net income, which is determined in accordance with GAAP.

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

 

March 31,

 

 

(In millions, except per share data)

 

2025

 

2024

 

 

Net loss

 

$

(79.0

)

 

$

(75.5

)

 

 

Interest expense, net

 

 

66.6

 

 

 

63.0

 

 

 

Provision for income taxes

 

 

6.6

 

 

 

5.4

 

 

 

Depreciation and amortization (a)

 

 

36.0

 

 

 

45.0

 

 

 

EBITDA

 

$

30.2

 

 

$

37.9

 

 

 

Loss on financing transactions (b)

 

 

24.9

 

 

 

 

 

Selling, general, and administrative expenses, Other expense (income), net

Net gain on disposition of businesses and assets

 

 

 

 

 

(3.6

)

 

Selling, general, and administrative expenses

Restructuring and other charges (c)

 

 

7.4

 

 

 

9.4

 

 

Selling, general, and administrative expenses

Other items (d)

 

 

2.3

 

 

 

1.3

 

 

Selling, general, and administrative expenses

Adjusted EBITDA

 

$

64.8

 

 

$

45.0

 

 

 

Adjusted EBITDA to Adjusted Net Loss:

 

 

 

 

 

 

 

 

Adjusted EBITDA

 

 

64.8

 

 

 

45.0

 

 

 

Interest expense, net

 

 

66.6

 

 

 

63.0

 

 

 

Provision for income taxes – Adjusted (e)

 

 

1.2

 

 

 

4.2

 

 

 

Depreciation and amortization – Adjusted (f)

 

 

45.5

 

 

 

46.3

 

 

 

Adjusted Net Loss

 

$

(48.5

)

 

$

(68.5

)

 

 

Adjusted EPS

 

$

(1.37

)

 

$

(1.94

)

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA by Segment:

 

 

 

 

 

 

 

 

Engineered Materials

 

$

25.7

 

 

$

10.4

 

 

 

Latex Binders

 

 

24.5

 

 

 

25.7

 

 

 

Polymer Solutions

 

 

44.5

 

 

 

29.1

 

 

 

Americas Styrenics

 

 

(1.8

)

 

 

6.2

 

 

 

Corporate Unallocated

 

 

(28.1

)

 

 

(26.4

)

 

 

Adjusted EBITDA

 

$

64.8

 

 

$

45.0

 

 

 

_________________________

(a)

During the three months ended March 31, 2025, an $8.1 million benefit was recognized due to a change in cost estimate related to the Boehlen, Germany asset retirement obligation as the Company was able to realize efficiencies during decommissioning.

(b)

Amounts for the three months ended March 31, 2024 primarily relate to fees incurred in conjunction with Company’s debt refinancing transaction that did not meet the criteria for deferred financing charges.

(c)

Restructuring and other charges for the 2025 and 2024 periods primarily relate to employee termination benefits, contract termination costs as well as decommissioning and other charges incurred in connection with the Company’s restructuring plans.

(d)

Other items for the 2025 period primarily relate to fees incurred in conjunction with certain of the Company’s strategic initiatives, including the potential divestiture of our styrenics business. Other items for the 2024 period primarily relate to fees incurred in conjunction with certain of the Company’s strategic initiatives, as well as costs related to our transition to a new enterprise resource planning system.

(e)

Adjusted to remove the tax impact of the items noted within the table above. The income tax expense (benefit) related to these items was determined utilizing either (1) the estimated annual effective tax rate on our ordinary income based upon our forecasted ordinary income for the full year or, (2) for items treated discretely for tax purposes we utilized the applicable rates in the taxing jurisdictions in which these adjustments occurred.

(f)

Amounts for the three months ended March 31, 2025 and 2024 excludes accelerated depreciation of $9.4 million and $1.3 million, respectively. The 2025 and 2024 period charges are primarily related to the shortening of the useful life of certain assets related to the 2024 restructuring plan.

For the same reasons discussed above, we are providing the following reconciliation of forecasted net loss to forecasted Adjusted EBITDA, Adjusted Net Loss and Adjusted EPS for the three months ended June 30, 2025. See “Note on Forward-Looking Statements” above for a discussion of the limitations of these forecasts. Totals may not sum due to rounding.

 

 

 

 

 

 

Three Months Ended

 

 

June 30,

(In millions, except per share data)

 

2025

Adjusted EBITDA

 

$

55 – 70

Interest expense, net

 

 

67

Provision for income taxes

 

 

6

Depreciation and amortization

 

 

43

Reconciling items to Adjusted EBITDA (g)

 

 

Net Loss

 

 

(61) – (46)

Reconciling items to Adjusted Net Loss (g)

 

 

Adjusted Net Loss

 

$

(61) – (46)

 

 

 

 

Weighted average shares – diluted (h)

 

 

35.5

EPS – diluted ($)

 

$

(1.72) – (1.30)

Adjusted EPS ($)

 

$

(1.72) – (1.30)

(g)

Reconciling items to Adjusted EBITDA and Adjusted Net Income (Loss) are not typically forecasted by the Company based on their nature as being primarily driven by transactions that are not part of the core operations of the business and, as a result, cannot be estimated without unreasonable cost or uncertainty. As such, for the forecasted second quarter ended June 30, 2025, we have not included estimates for these items.

(h)

Weighted average shares presented for the purpose of forecasting EPS and Adjusted EPS assume that the Company will be in a net loss position for second quarter 2025, and therefore excludes the impact of potentially dilutive shares, as the inclusion of said shares would have an anti-dilutive effect. Further, the weighted average shares presented do not forecast significant future share transactions or events, such as repurchases, significant share-based compensation award grants, and changes in the Company’s share price. These are all factors which could have a significant impact on the calculation of EPS and Adjusted EPS during actual future periods.

Note 3: Reconciliation of Non-GAAP Liquidity Measures to Cash from Operations

The Company uses certain measures, such as Free Cash Flow as non-GAAP measures, to evaluate and discuss its liquidity position and results. Free Cash Flow is defined as cash from operating activities, less capital expenditures. We believe that Free Cash Flow provides an indicator of the Company’s ongoing ability to generate cash through core operations, as it excludes the cash impacts of various financing transactions as well as cash flows from business combinations that are not considered organic in nature. We also believe that Free Cash Flow provides management and investors with useful analytical indicators of our ability to service our indebtedness, pay dividends (when declared), and meet our ongoing cash obligations.

Free Cash Flow is not intended to represent cash flows from operations as defined by GAAP, and therefore, should not be used as alternatives for that measure. Other companies in our industry may define Free Cash Flow differently than we do. As a result, it may be difficult to use this or similarly named financial measures that other companies may use, to compare the liquidity and cash generation of those companies to our own. The Company compensates for these limitations by providing the following detail, which is determined in accordance with GAAP.

Free Cash Flow

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

March 31,

(In millions)

 

2025

 

2024

Cash used in operating activities

 

$

(110.2)

 

$

(66.2)

Capital expenditures

 

 

(8.7)

 

 

(15.7)

Free Cash Flow

 

$

(118.9)

 

$

(81.9)

 

Bee van Kessel

Tel: +41 44 718 3685

Email: [email protected]

KEYWORDS: United States North America Pennsylvania

INDUSTRY KEYWORDS: Automotive Manufacturing Manufacturing Other Manufacturing Packaging Chemicals/Plastics

MEDIA:

Logo
Logo

Osisko Declares 20% Increase in Second Quarter 2025 Dividend

MONTREAL, May 07, 2025 (GLOBE NEWSWIRE) — Osisko Gold Royalties Ltd (the “Company” or “Osisko”) (OR: TSX & NYSE) is pleased to announce that the Board of Directors has approved a second quarter 2025 dividend of US$0.055 per common share, a 20% increase over the previous quarterly dividend, based on the foreign exchange rate (C$/US$) on the declaration date of the first quarter dividend. The dividend will be paid on July 15, 2025 to shareholders of record as of the close of business on June 30, 2025. This dividend is an “eligible dividend” as defined in the Income Tax Act (Canada).

For shareholders residing in Canada, the Canadian dollar equivalent will be determined based on the daily rate published by the Bank of Canada on June 30, 2025.

The Company also wishes to remind its shareholders that it has implemented a dividend reinvestment plan (the “Plan”). Shareholders who are residents of Canada and the United States may elect to participate in the Plan in connection with the dividend to be paid on July 15, 2025 to shareholders on record as of June 30, 2025. More details are available on Osisko’s website at http://osiskogr.com/en/dividends/drip/

Non-registered beneficial shareholders who wish to participate in the Plan should contact their financial advisor, broker, investment dealer, bank or other financial institution that holds their common shares to inquire about the applicable enrolment deadline and to request enrolment in the Plan. For more information on how to enroll or any other inquiries, contact our transfer agent at 1-800-387-0825 (toll-free in Canada) or [email protected].

Participation in the Plan does not relieve shareholders of any liability for taxes that may be payable in respect of dividends that are reinvested in common shares under the Plan. Shareholders should consult their tax advisors concerning the tax implications of their participation in the Plan having regard to their particular circumstances.

This press release is not an offer to sell or a solicitation of an offer to buy any securities in the United States or any other jurisdiction.

About Osisko Gold Royalties Ltd

Osisko is an intermediate precious metals royalty company focused on the Americas that commenced activities in June 2014. Osisko holds a North American and Australian focused portfolio of over 195 royalties, streams and precious metal offtakes. Osisko’s portfolio is anchored by its cornerstone asset, a 3-5% net smelter return royalty on the Canadian Malartic Complex, one of Canada’s largest gold mines.

Osisko’s head office is located at 1100 Avenue des Canadiens-de-Montréal, Suite 300, Montréal, Québec, H3B 2S2.

For further information, please contact Osisko Gold Royalties Ltd:

Grant Moenting
Vice President, Capital Markets
Tel: (514) 940-0670 #116
Mobile: (365) 275-1954
Email: [email protected]

Heather Taylor
Vice President, Sustainability & Communications
Tel: (514) 940-0670 #105
Email: [email protected]



Forward-looking statements

Certain statements contained in this press release may be deemed “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and “forward-looking information” within the meaning of applicable Canadian securities legislation. These forward-looking statements, by their nature, require the Company to make certain assumptions and necessarily involve known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied in these forward-looking statements. Forward-looking statements are not guarantees of performance. In this news release, these forward-looking statements may involve, but are not limited to, comments with respect to the directors and officers of the Company, information pertaining to the fact
that all conditions for payment of the dividend will be met and that such dividend will continue to be an “eligible dividend” as defined in the Income Tax Act (Canada). Words such as “may”, “will”, “would”, “could”, “expect”, “believe”, “plan”, “anticipate”, “intend”, “estimate”, “continue”, or the negative or comparable terminology, as well as terms usually used in the future and the conditional, are intended to identify forward-looking statements. Information contained in forward-looking statements is based upon certain material assumptions that were applied in drawing a conclusion or making a forecast or projection, including that the financial situation of the Company will remain favourable. The Company considers its assumptions to be reasonable based on information currently available, but cautions the reader that its assumptions regarding future events, many of which are beyond the control of the Company, may ultimately prove to be incorrect since they are subject to risks and uncertainties that affect the Company and its business.

For additional information with respect to these and other factors and assumptions underlying the forward-looking statements made in this press release, see the section entitled “Risk Factors” in the most recent Annual Information Form of Osisko which is filed with the Canadian securities commissions and available electronically under Osisko’s issuer profile on SEDAR+ at

www.sedarplus.com

and with the U.S. Securities and Exchange Commission and available electronically under Osisko’s issuer profile on EDGAR at

www.sec.gov

. The forward-looking information set forth herein reflects Osisko’s expectations as at the date of this press release and is subject to change after such date. Osisko disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, other than as required by law.



Pan American Silver Reports Unaudited First Quarter 2025 Results

Pan American Silver Reports Unaudited First Quarter 2025 Results

 Basic Earnings of $0.47 per Share

All amounts expressed in U.S. dollars unless otherwise indicated. Unaudited tabular amounts are in millions of U.S. dollars and thousands of shares, options, and warrants except per share amounts and per ounce amounts, unless otherwise noted.

VANCOUVER, British Columbia–(BUSINESS WIRE)–Pan American Silver Corp. (NYSE: PAAS) (TSX: PAAS) (“Pan American” or the “Company”) reports unaudited results for the quarter ended March 31, 2025 (“Q1 2025”).

“Pan American has had a strong start to 2025, delivering another quarter of solid operating results. Lower costs and higher metal prices resulted in a record $250.8 million of mine operating earnings and $112.6 million in free cash flow,” said Michael Steinmann, President and Chief Executive Officer. “We are on track to achieve our guidance for 2025, with production levels expected to increase over the coming quarters from a back-end loaded production profile. We remain focused on progressing our initiatives to further increase shareholder value, including the optimization study for Jacobina, development of the La Colorada Skarn, and the consultation process for Escobal.”

The following highlights for Q1 2025 include certain measures that are not generally accepted accounting principles (“non-GAAP”) financial measures. Please refer to the section titled “Alternative Performance (Non-GAAP) Measures” at the end of this news release for further information on these measures.

Consolidated Q1 2025 Results:

  • Silver production of 5.0 million ounces.
  • Gold production of 182.2 thousand ounces.
  • Revenue of $773.2 million.
  • Net earnings of $169.3 million, or $0.47 basic earnings per share.
  • Adjusted earnings of $153.0 million, or $0.42 adjusted earnings per share.
  • Cash flow from operations before non-cash working capital changes of $240.1 million, net of $95.1 million in cash taxes paid ($174.8 million after changes in non-cash working capital).
  • Silver Segment All-in Sustaining Costs (“AISC”)(1) per silver ounce of $13.94.
  • Gold Segment AISC(2), excluding net realizable value (“NRV”) inventory adjustments, per gold ounce of $1,485.
  • Cash and short-term investments increased by $35.7 million from December 31, 2024 to $923.0 million.
  • As at March 31, 2025, the Company had working capital of $1,161.8 million and $750.0 million available under its undrawn credit facility (“Credit Facility”). Total debt of $804.4 million is primarily related to two senior notes, as well as certain lease liabilities and construction loans payable.
  • The Company maintains its 2025 Operating Outlook, as previously provided in its Management’s Discussion & Analysis (“MD&A”) dated February 19, 2025. See the “2025 Operating Outlook” section of this news release for further detail.
  • A cash dividend of $0.10 per common share with respect to Q1 2025 was declared on May 7, 2025, payable on or about June 2, 2025, to holders of record of Pan American’s common shares as of the close of markets on May 20, 2025. During Q1 2025, the Company paid cash dividends to its shareholders totaling $36.2 million. The dividends are eligible dividends for Canadian income tax purposes.
  • The Company repurchased for cancellation 909,012 common shares in Q1 2025 at an average price of $22.00 per share for a total consideration of $20.0 million under its Normal Course Issuer Bid, which was renewed on March 6, 2025.

(1) Silver Segment AISC is calculated net of credits for realized revenues from all metals other than silver and is calculated per ounce of silver sold.

(2) Gold Segment AISC is calculated net of credits for realized revenues from all metals other than gold and is calculated per ounce of gold sold.

Q1 2025 Project Updates:

  • At the La Colorada mine, project capital of $4.9 million was directed largely to the current vein mining operation for exploration and mine equipment leases to access, mine, and expand mineral resource extensions in the eastern and southeastern higher-grade Candelaria zone.
  • With respect to the La Colorada Skarn, project capital of $3.0 million was largely for exploration and in-fill drilling and advancing engineering work. Pan American is currently discussing potential partnerships for development of the project.
  • At Huaron, $3.0 million of project capital was related to residual accounts payable settlements for the drystack tailings storage facility, which was completed in the fourth quarter of 2024, and is now fully commissioned and operating.
  • At Jacobina, project capital of $4.8 million was allocated to mine and plant optimization studies aimed at maximizing long-term economic performance.
  • At Timmins, project capital of $2.9 million was related to underground development advances to provide access for exploration drilling of adjacent prospective deposits.
  • At Escobal, Pan American had four working meetings with the Guatemalan government during Q1 2025 as part of the ILO 169 consultation process. Currently, there is no date for the completion of the consultation process or the potential restart of operations at Escobal.

CONSOLIDATED RESULTS

 

Three months

ended March 31,

2025

Three months

ended March 31,

2024

Weighted average shares during period

 

362,408

 

 

364,486

 

Shares outstanding end of period

 

362,190

 

 

362,940

 

 

 

 

 

Three months ended

March 31,

 

 

2025

 

 

2024

 

FINANCIAL

 

 

Revenue

$

773.2

$

601.4

 

Cost of Sales(1)

$

522.4

 

$

530.4

 

Mine operating earnings

$

250.8

 

$

71.0

 

Net earnings (loss)

$

169.3

 

$

(30.8

)

Basic earnings (loss) per share(2)

$

0.47

 

$

(0.08

)

Adjusted earnings(3)

$

153.0

 

$

4.7

 

Basic adjusted earnings per share(2)(3)

$

0.42

 

$

0.01

 

Net cash generated from operating activities

$

174.8

 

$

61.1

 

Net cash generated from operating activities before changes in working capital(3)

$

240.1

 

$

127.1

 

Sustaining capital expenditures(3)

$

62.2

 

$

65.7

 

Project capital expenditures(3)(4)

$

18.6

 

$

30.9

 

Cash dividend paid per share

$

0.10

 

$

0.10

 

PRODUCTION

 

 

Silver (thousand ounces)

 

5,003

 

 

5,009

 

Gold (thousand ounces)

 

182.2

 

 

222.9

 

Zinc (thousand tonnes)

 

14.0

 

 

9.8

 

Lead (thousand tonnes)

 

6.7

 

 

4.6

 

Copper (thousand tonnes)

 

0.6

 

 

1.7

 

AISC(3) ($/ounce)

 

 

Silver Segment

 

13.94

 

 

16.63

 

Gold Segment

 

1,485

 

 

1,499

 

AVERAGE REALIZED PRICES(5)

 

 

Silver ($/ounce)

 

31.25

 

 

22.61

 

Gold ($/ounce)

 

2,868

 

 

2,078

 

Zinc ($/tonne)

 

2,819

 

 

2,424

 

Lead ($/tonne)

 

1,974

 

 

2,063

 

Copper ($/tonne)

 

9,287

 

 

8,373

 

(1)

Cost of Sales includes production costs, depreciation and amortization and royalties.

(2)

Per share amounts are based on basic weighted average common shares.

(3)

Non-GAAP measure; please refer to the “Alternative Performance (non-GAAP) Measures” section of this news release for further information on these measures. The AISC are excluding NRV inventory adjustments.

(4)

Project capital relates to expenditures at the La Colorada mine, the La Colorada Skarn, and the Huaron, Timmins and Jacobina mines.

(5)

Metal prices stated are inclusive of final settlement adjustments on concentrate sales.

Q1 2025 OPERATING PERFORMANCE

 

 

 

 

Silver Production

(thousand ounces)

Gold Production

(thousand ounces)

AISC

($ per ounce)(1)

Silver Segment

 

 

 

La Colorada (Mexico)

1,389

1.2

19.72

Cerro Moro (Argentina)

545

20.6

(4.40)

Huaron (Peru)

951

13.09

San Vicente (Bolivia)(2)

643

19.70

Total Silver Segment(3)

3,528

21.7

13.94

Gold Segment

 

 

 

Jacobina (Brazil)

1

45.1

1,243

El Peñon (Chile)

945

28.2

1,214

Timmins (Canada)

4

28.5

2,124

Shahuindo (Peru)

65

29.5

1,440

Minera Florida (Chile)

112

15.2

2,445

Dolores (Mexico)

349

14.0

569

Total Gold Segment(3)

1,476

160.5

1,485

Total Consolidated(3)

5,003

182.2

 

(1)

Non-GAAP measure; please refer to the “Alternative Performance (non-GAAP) Measures” section of this news release for further information on these measures. The AISC are excluding NRV inventory adjustments.

(2)

San Vicente data represents Pan American’s 95.0% interest in the mine’s production.

(3)

Totals may not add due to rounding.

2025 OPERATING OUTLOOK

The Company reaffirms its 2025 Operating Outlook for annual production, AISC, and capital expenditures, as summarized in the table below.

Please see Pan American’s MD&A dated February 19, 2025, for further detail on the Company’s 2025 Operating Outlook, including the quarterly outlook for production and AISC. Please also refer to the Cautionary Note Regarding Forward-Looking Statements and Information at the end of this news release.

 

2025 Annual Guidance

Silver Production (million ounces)

20.00 – 21.00

Gold Production (thousand ounces)

735 – 800

Silver Segment AISC(1) ($ per ounce)

16.25 – 18.25

Gold Segment AISC (1) ($ per ounce)

1,525 – 1,625

Sustaining Capital Expenditures ($ millions)

270.0 – 285.0

Project Capital Expenditures ($ millions)

90.0 – 100.0

(1)

AISC is a non-GAAP measure. Please refer to the “Alternative Performance (Non-GAAP) Measures” section of this news release for further information on these measures. The AISC forecast assumes average metal prices of $30.00/oz for silver, $2,650/oz for gold, $3,000/tonne ($1.36/lb) for zinc, $2,000/tonne ($0.91/lb) for lead, and $9,500/tonne ($4.31/lb) for copper; and average annual exchange rates relative to 1 USD of 20.00 for the Mexican peso (“MXN”), 3.75 for the Peruvian sol (“PEN”), 1,177.00 for the Argentine peso (“ARS”), 7.00 for the Bolivian boliviano (“BOB”), 1.38 for the Canadian dollar (“CAD”), 950.00 for the Chilean peso (“CLP”) and 5.75 for the Brazilian real (“BRL”).

AISC, adjusted earnings, basic adjusted earnings per share, sustaining and project capital, free cash flow, working capital, and total debt are non-GAAP financial measures. Please refer to the “Alternative Performance (non-GAAP) Measures” section of this news release for further information on these measures.

This news release should be read in conjunction with Pan American’s Unaudited Condensed Interim Consolidated Financial Statements and our MD&A for the three months ended March 31, 2025. This material is available on Pan American’s website at https://panamericansilver.com/invest/financial-reports-and-filings/ on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov.

CONFERENCE CALL AND WEBCAST

Date: May 8, 2025

Time: 11:00 am ET (8:00 am PT)

Webcast:https://event.choruscall.com/mediaframe/webcast.html?webcastid=RKB97YTl [event.choruscall.com]

Conference Call: Participants can register for the conference call at: https://dpregister.com/DiamondPassRegistration/register?confirmationNumber=10197324&linkSecurityString=fe98743a80

Upon registration, you will receive the dial-in details and a unique PIN to access the call. This process will bypass the live operator and avoid the queue. Registration will remain open until the end of the live conference call.

Those without internet access or who prefer to speak with an operator may dial:

1-833-752-3507 (toll-free in Canada and the U.S.)

1-647-846-7282 (International Participants)

Visit https://panamericansilver.com/invest/events-and-presentations/ to access the webcast, presentation slides and the MD&A for the period ended March 31, 2025. An archive of the webcast will also be available for three months at panamericansilver.com.

About Pan American

Pan American is a leading producer of silver and gold in the Americas, operating mines in Canada, Mexico, Peru, Brazil, Bolivia, Chile and Argentina. We also own the Escobal mine in Guatemala that is currently not operating, and we hold interests in exploration and development projects. We have been operating in the Americas for over three decades, earning an industry-leading reputation for sustainability performance, operational excellence and prudent financial management. We are headquartered in Vancouver, B.C. and our shares trade on the New York Stock Exchange and the Toronto Stock Exchange under the symbol “PAAS”.

Learn more at panamericansilver.com

Follow us on LinkedIn

Alternative Performance (Non-GAAP) Measures

In this news release, we refer to measures that are non-GAAP financial measures. These measures are widely used in the mining industry as a benchmark for performance, but do not have a standardized meaning as prescribed by IFRS as an indicator of performance, and may differ from methods used by other companies with similar descriptions. These non-GAAP financial measures include:

  • Adjusted earnings and basic adjusted earnings per share. Pan American believes that these measures better reflect normalized earnings as they eliminate items that in management’s judgment are subject to volatility as a result of factors, which are unrelated to operations in the period, and/or relate to items that will settle in future periods.
  • All-in Sustaining Costs (“AISC”) per silver or gold ounce sold, net of by-product credits. Pan American believes that AISC, calculated net of by-products, is a comprehensive measure of the full cost of operating our consolidated business, given it includes the cost of replacing silver and gold ounces through exploration, the cost of ongoing capital investments at current operations (“sustaining capital”), as well as other items that affect the Company’s consolidated cash flow. AISC excludes capital investments that are expected to increase production levels or mine life beyond those contemplated in the base case life of mine plan (“project capital”).
  • Total debt is calculated as the total current and non-current portions of: debt, including senior notes and amounts drawn on the Credit Facility, and lease obligations. Total debt does not have any standardized meaning prescribed by GAAP and is therefore unlikely to be comparable to similar measures presented by other companies. Pan American and certain investors use this information to evaluate the financial debt leverage of Pan American.
  • Working capital is calculated as current assets less current liabilities. Working capital does not have any standardized meaning prescribed by GAAP and is therefore unlikely to be comparable to similar measures presented by other companies. Pan American and certain investors use this information to evaluate whether Pan American is able to meet its current obligations using its current assets.
  • Project capital relates to expenditures at the La Colorada mine, the La Colorada Skarn, and the Huaron, Timmins and Jacobina mines. Project capital does not have any standardized meaning prescribed by GAAP and is therefore unlikely to be comparable to similar measures presented by other companies. Pan American and certain investors use this information to evaluate capital investments that are directed at increasing production levels or mine life beyond those contemplated in the base case life of mine plan.
  • Free cash flow is calculated as net cash generated from operating activities less sustaining capital expenditures. Free cash flow does not have any standardized meaning prescribed by GAAP and is therefore unlikely to be comparable to similar measures presented by other companies. Pan American and certain investors use this information to evaluate the profitability of Pan American and identify capital that may be available for investment or return to shareholders.

Readers should refer to the “Alternative Performance (non-GAAP) Measures” section of Pan American’s Q1 2025 MD&A for a more detailed discussion of these and other non-GAAP measures and their calculation.

Cautionary Note Regarding Forward-Looking Statements and Information

Certain of the statements and information in this news release constitute “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and “forward-looking information” within the meaning of applicable Canadian provincial securities laws. All statements, other than statements of historical fact, are forward-looking statements or information. Forward-looking statements or information in this news release relate to, among other things: future financial or operational performance, including our estimated production of silver, gold and other metals forecasted for 2025, our estimated AISC, and our sustaining and project capital expenditures in 2025; the anticipated dividend payment date of June 2, 2025; our ability to complete or advance the optimization study for Jacobina, the development of the La Colorada Skarn, or the consultation process for Escobal, and any anticipated benefits to shareholder value or financial or operational performance that may be derived therefrom; expectations regarding the ILO 169 consultation process with respect to Escobal; and Pan American’s plans and expectations for its properties and operations.

These forward-looking statements and information reflect Pan American’s current views with respect to future events and are necessarily based upon a number of assumptions that, while considered reasonable by Pan American, are inherently subject to significant operational, business, economic and regulatory uncertainties and contingencies. These assumptions include: the impact of inflation and disruptions to the global, regional and local supply chains; tonnage of ore to be mined and processed; future anticipated prices for gold, silver and other metals and assumed foreign exchange rates; the timing and impact of planned capital expenditure projects, including anticipated sustaining, project, and exploration expenditures; the ongoing impact and timing of the court-mandated ILO 169 consultation process in Guatemala; ore grades and recoveries; capital, decommissioning and reclamation estimates; our mineral reserve and mineral resource estimates and the assumptions upon which they are based; prices for energy inputs, labour, materials, supplies and services (including transportation); no labour-related disruptions at any of our operations; no unplanned delays or interruptions in scheduled production; all necessary permits, licenses and regulatory approvals for our operations are received in a timely manner; our ability to secure and maintain title and ownership to mineral properties and the surface rights necessary for our operations; whether Pan American is able to maintain a strong financial condition and have sufficient capital, or have access to capital through our corporate Credit Facility or otherwise, to sustain our business and operations; and our ability to comply with environmental, health and safety laws. The foregoing list of assumptions is not exhaustive.

Pan American cautions the reader that forward-looking statements and information involve known and unknown risks, uncertainties and other factors that may cause actual results and developments to differ materially from those expressed or implied by such forward-looking statements or information contained in this news release and Pan American has made assumptions and estimates based on or related to many of these factors. Such factors include, without limitation: the duration and effect of local and world-wide inflationary pressures and the potential for economic recessions; fluctuations in silver, gold and base metal prices; fluctuations in prices for energy inputs, labour, materials, supplies and services (including transportation); fluctuations in currency markets (such as the PEN, MXN, ARS, BOB, GTQ, CAD, CLP and BRL versus the USD); operational risks and hazards inherent with the business of mining (including environmental accidents and hazards, industrial accidents, equipment breakdown, unusual or unexpected geological or structural formations, cave-ins, flooding and severe weather); risks relating to the credit worthiness or financial condition of suppliers, refiners and other parties with whom Pan American does business; inadequate insurance, or inability to obtain insurance, to cover these risks and hazards; employee relations; relationships with, and claims by, local communities and indigenous populations; our ability to obtain all necessary permits, licenses and regulatory approvals in a timely manner; changes in laws, regulations and government practices in the jurisdictions where we operate, including environmental, export and import laws and regulations; changes in national and local government, legislation, taxation, controls or regulations and political, legal or economic developments in Canada, the United States, Mexico, Peru, Argentina, Bolivia, Guatemala, Chile, Brazil or other countries where Pan American may carry on business, including legal restrictions relating to mining, risks relating to expropriation and risks relating to the constitutional court-mandated ILO 169 consultation process in Guatemala; unanticipated or excessive tax assessments or reassessments in our operating jurisdictions; diminishing quantities or grades of mineral reserves as properties are mined; increased competition in the mining industry for equipment and qualified personnel; and those factors identified under the caption “Risks Related to Pan American’s Business” in Pan American’s most recent form 40-F and Annual Information Form filed with the United States Securities and Exchange Commission and Canadian provincial securities regulatory authorities, respectively.

Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated, described or intended. Investors are cautioned against attributing undue certainty or reliance on forward-looking statements or information. Forward-looking statements and information are designed to help readers understand management’s current views of our near- and longer-term prospects and may not be appropriate for other purposes. The Company does not intend, nor does it assume any obligation, to update or revise forward-looking statements or information to reflect changes in assumptions or in circumstances or any other events affecting such statements or information, other than as required by applicable law.

For more information contact:

Siren Fisekci

VP, Investor Relations & Corporate Communications

Ph: 604-806-3191

Email: [email protected]

KEYWORDS: North America Bolivia Latin America Peru Chile Guatemala Mexico Canada Australia Argentina Africa Australia/Oceania United States Brazil South America Central America Nevada Colorado Idaho Arizona

INDUSTRY KEYWORDS: Mining/Minerals Natural Resources

MEDIA:

Logo
Logo

Nutrien Declares Quarterly Dividend of US$0.545 per Share

Nutrien Declares Quarterly Dividend of US$0.545 per Share

SASKATOON, Saskatchewan–(BUSINESS WIRE)–
Nutrien Ltd. (TSX and NYSE: NTR) announced today that its Board of Directors has declared a quarterly dividend of US$0.545 per share payable on July 18, 2025, to shareholders of record on June 30, 2025.

Registered shareholders who are residents of Canada as reflected in Nutrien’s shareholders register, as well as beneficial holders (i.e., shareholders who hold their common shares through a broker or other intermediary) whose intermediary is a participant in CDS Clearing and Depositary Services Inc. or its nominee, CDS & Co., will receive their dividend in Canadian dollars, calculated based on the Bank of Canada daily average exchange rate on June 30, 2025. Registered shareholders resident outside of Canada as reflected in Nutrien’s shareholders register, including the United States, as well as beneficial holders whose intermediary is a participant in The Depository Trust Company or its nominee, Cede & Co., will receive their dividend in US dollars. However, registered shareholders of Nutrien may elect to change the currency of their dividend payments to US dollars or Canadian dollars, as applicable. In addition, Nutrien offers registered shareholders direct deposit by electronic funds transfer for dividend payments.

Registered shareholders may elect to change the currency of their dividend and enroll for direct deposit by contacting, Nutrien’s registrar and transfer agent, Computershare Investor Services Inc., directly (1-800-564-6253 or [email protected]). Beneficial shareholders should contact their broker or other intermediary to determine the ability and necessary steps involved in an election to change the currency of their dividend payment. For further details, please visit www.nutrien.com/investors/shareholder-information/dividends.

All dividends paid by Nutrien are, pursuant to subsection 89(14) of the Income Tax Act (Canada), designated as eligible dividends.

About Nutrien

Nutrien is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve the needs of growers. We focus on creating long-term value by prioritizing investments that strengthen the advantages of our business across the ag value chain and by maintaining access to the resources and the relationships with stakeholders needed to achieve our goals.

Jeff Holzman

Vice President, Investor Relations

(306) 933-8545

Contact us at: www.nutrien.com

KEYWORDS: North America Canada

INDUSTRY KEYWORDS: Agriculture Natural Resources

MEDIA:

Logo
Logo

Centrus Reports First Quarter 2025 Results

PR Newswire

  • Net income of $27.2 million on $73.1 million in revenue, compared to a net loss of $6.1 million on $43.7 million in revenue in Q1 2024
  • Retired our higher-interest rate debt (8.25% Notes) at a redemption price equal to the principal of $74.3 million plus any accrued and unpaid interest, resulting in a gain of $11.8 million in Q1 2025
  • Consolidated cash balance of $653.0 million as of March 31, 2025

BETHESDA, Md., May 7, 2025 /PRNewswire/ — Centrus Energy Corp. (NYSE American: LEU) (“Centrus” or the “Company”) today reported first quarter 2025 results. The Company reported net income of $27.2 million for the three months ended March 31, 2025, which is $1.60 (basic and diluted) per common share.

“This was a strong first quarter for Centrus as we delivered robust financial results,” said Centrus President and CEO Amir Vexler. “Our operations have not been impacted by tariffs, and we are well positioned to execute on our expansion plans once federal funding decisions are made. We are confident in our compelling investment case for the $3.4 billion in funding that Congress has provided to jumpstart domestic nuclear fuel production. Centrus is the only company currently enriching uranium with U.S.-owned, U.S.-origin technology backed by an American supply chain and powered by American workers that can meet national security needs. This is not the time to send hard-earned U.S. taxpayer dollars overseas and reinforce the monopoly of the foreign, state-owned companies that already dominate the market.”

“Our continuous, reliable, and safe enrichment operations for the government, along with our track record of achieving milestones on schedule and on budget, provide us with the confidence to restore America’s ability to enrich uranium at scale.”

Financial Results

Centrus generated total revenue of $73.1 million and $43.7 million for the three months ended March 31, 2025 and 2024, respectively, an increase of $29.4 million (or 67%).

Revenue from the LEU segment was $51.3 million and $23.6 million for the three months ended March 31, 2025 and 2024, respectively, an increase of $27.7 million (or 117%). SWU revenue increased by $27.7 million as a result of a 46% increase in the average price of SWU sold and a 49% increase in the volume of SWU sold.

Revenue from the Technical Solutions segment was $21.8 million and $20.1 million for the three months ended March 31, 2025 and 2024, respectively, an increase of $1.7 million (or 8%). The increase in revenue is primarily attributable to a $2.0 million increase in revenue generated by the HALEU Operation Contract. Revenue from the HALEU Operation Contract is recorded on a cost-plus-incentive-fee basis and includes a target fee for Phase 2 of the contract.

Cost of sales for the LEU segment was $20.1 million and $23.1 million for the three months ended March 31, 2025 and 2024, respectively, a decrease of $3.0 million (or 13%). SWU costs decreased as a result of a 48% decrease in the average unit cost of SWU sold, partially offset by a 49% increase in the volume of SWU sold. Cost of sales for the three months ended March 31, 2025 and 2024, included $2.1 million and $0.3 million, respectively, for the revaluation of inventory loans.

Cost of sales for the Technical Solutions segment was $20.1 million and $16.3 million for the three months ended March 31, 2025 and 2024, respectively, an increase of $3.8 million (or 23%). The increase is primarily attributable to a $4.1 million increase in costs incurred under the HALEU Operation Contract, partially offset by a decrease in costs related to other contracts.

The Company recognized a gross profit of $32.9 million and $4.3 million for the three months ended March 31, 2025 and 2024, respectively, an increase of $28.6 million (or 665%).

Gross profit for the LEU segment was $31.2 million and $0.5 million for the three months ended March 31, 2025 and 2024, respectively, an increase of $30.7 million (or 6,140%). LEU customers generally have multi-year contracts that carry annual purchase commitments, not quarterly commitments. The gross profit in our LEU business varies based upon the timing of those contracts. The pricing applied to deliveries varies depending upon the market conditions at the time the contract was signed. The increase for the three months ended March 31, 2025 was due to the increase in sales volume and composition of contracts in the current quarter.

Gross profit for the Technical Solutions segment was $1.7 million and $3.8 million for the three months ended March 31, 2025 and 2024, respectively, a decrease of $2.1 million (or 55%). The decrease was primarily attributable to the factors discussed above. Because of the delay in obtaining sufficient storage cylinders to complete Phase 2 of the HALEU Operation Contract, in November 2024, DOE extended Phase 2 to June 30, 2025. Costs incurred subsequent to the extension have not yet been subject to a fee, but Centrus expects the fee to be recovered later this year once the extension is definitized.

Domestic Enrichment Update

Centrus is continuing to produce HALEU at its American Centrifuge Plant in Piketon, Ohio, under the HALEU Operation Contract with the DOE. The DOE is contractually required to provide storage cylinders necessary to collect the HALEU uranium hexafluoride (“UF6“) product from Centrus’ centrifuge cascade. Using the storage cylinders currently made available by the DOE, Centrus achieved cumulative deliveries to the DOE of approximately 670 kilograms of HALEU UF6 as of March 31, 2025. On November 5, 2024, the HALEU Operation Contract was modified to extend the Phase 2 period of performance to June 30, 2025. DOE has increased the Phase 2 contract value and related funding to $152.3 million.

On October 4, 2024, DOE selected ACO and five other awardees under the November 28, 2023 solicitation aimed at HALEU deconversion, a subsequent step in the HALEU production process. The HALEU Deconversion Contract has a minimum value of $2.0 million and a maximum aggregate value of $0.8 billion for all awardees. On October 16, 2024, DOE selected ACO and three other awardees under the January 9, 2024 competitive solicitation aimed at expanding domestic commercial production of HALEU, which is needed to fuel many of the next-generation nuclear reactor designs currently under development. The HALEU Production Contract has a minimum value of $2.0 million and a maximum aggregate value of $2.7 billion for all awardees. On December 10, 2024, DOE selected ACO and five other awardees under the June 27, 2024 solicitation aimed at expanding domestic commercial production of LEU. The LEU Production Contract has a minimum contract value of $2.0 million and a maximum value of $3.4 billion over a ten-year period for all awardees. The ultimate dollar amount under each contract and the potential scale of the expansion supported will depend upon the scope of task orders that DOE may subsequently issue under the contracts for which we will compete. On April 11, 2025, the Company was awarded a time and materials task order with a total award ceiling of $0.5 million under the LEU Enrichment Contract.

The two HALEU contracts and one LEU contract are backed in aggregate by more than $3.4 billion in appropriations that have been provided by Congress including $700 million appropriated through the Inflation Reduction Act of 2022 (“IRA”). Per Executive Order 14154, issued on January 20, 2025, all U.S. government executive agencies are directed to pause the distribution of all funding appropriated under the IRA for further review. The timing and outcome of such review is uncertain.

8.25% Notes due 2027

Pursuant to a notice of redemption issued on February 24, 2025, on March 26, 2025, the Company redeemed all 8.25% Notes at a redemption price equal to 100% of the $74.3 million aggregate principal amount, together with any accrued and unpaid interest. As of March 31, 2025, none of the 8.25% Notes remain outstanding. The Company recorded a gain of $11.8 million related to the extinguishment of the long-term debt in the three months ended March 31, 2025.

Backlog

The Company’s backlog is $3.8 billion as of March 31, 2025 and extends to 2040. Our LEU segment backlog as of March 31, 2025 is approximately $2.8 billion. The backlog is the estimated aggregate dollar amount of revenue for future SWU and uranium deliveries primarily under medium and long-term contracts with fixed commitments and approximately $2.1 billion in contingent LEU sales commitments, with $1.7 billion of the total under definitive agreements and $0.4 billion of the total subject to entering into definitive agreements, in support of potential construction of LEU production capacity at the Piketon, Ohio facility. The contingent LEU sales commitments also depend on our ability to secure substantial public and private investment. Our Technical Solutions segment backlog is approximately $0.9 billion as of March 31, 2025 and includes both funded amounts (services for which funding has been both authorized and appropriated by the customer), unfunded amounts (services for which funding has not been appropriated), and unexercised options.

About Centrus Energy Corp.

Centrus Energy is a trusted supplier of nuclear fuel components and services for the nuclear power industry. Centrus provides value to its utility customers through the reliability and diversity of its supply sources – helping them meet the growing need for clean, affordable, carbon-free electricity. Since 1998, the Company has provided its utility customers with more than 1,850 reactor years of fuel, which is equivalent to 7 billion tons of coal. With world-class technical and engineering capabilities, Centrus is pioneering production of High-Assay, Low-Enriched Uranium and is leading the effort to restore America’s uranium enrichment capabilities at scale to meet America’s clean energy, energy security, and national security needs. Find out more at centrusenergy.com.

Forward-Looking Statements:

This news release contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements related to future events, which may impact our expected future business and financial performance, and often contain words such as “expects”, “anticipates”, “intends”, “plans”, “believes”, “will”, “should”, “could”, “would” or “may” and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news release and represent management’s current views and assumptions with respect to future events and operational, economic and financial performance. Forward-looking statements are not guarantees of future performance, events or results and involve known and unknown risks, uncertainties and other factors, which may be beyond our control.

For Centrus Energy Corp., particular risks and uncertainties (hereinafter “risks”) that could cause our actual future results to differ materially from those expressed in our forward-looking statements and which are, and may be, exacerbated by any worsening of the global business and economic environment include but are not limited to the following: risks related to the geopolitical conflicts and the imposition of sanctions or other measures, including bans or tariffs, by (i) the U.S. or foreign governments and institutions such as the European Union, (ii) organizations (including the United Nations or other international organizations), or (iii) entities (including private entities or persons), that could directly or indirectly impact our financial position or ability to obtain, deliver, transport or sell low enriched uranium (“LEU”) or the Separative Work Units (“SWU”) and natural uranium hexafluoride components of LEU delivered to us under the existing supply contract with the Russian government-owned entity, TENEX, Joint-Stock Company (“TENEX”) (“TENEX Supply Contract”) or other supply contracts or make related payments or deliveries of natural uranium hexafluoride to TENEX; risks related to laws or other government measures that ban, delay or restrict (i) imports of Russian LEU into the United States, including but not limited to the “Prohibiting Russian Uranium Imports Act” enacted in May 2024 that bans imports of LEU from Russia into the U.S., effective August 11, 2024, subject to issuance of waivers by the DOE (“Import Ban Act”), (ii) transactions with Rosatom or its subsidiaries which include TENEX, or (iii) exports of Russian LEU from Russia to the United States or any entity that is a U.S. entity or that transacts with a U.S. entity (including but not limited to Russian Federal Decree No. 1544 that rescinded TENEX’s general license to export LEU to the United States or to entities registered in the United States through December 31, 2025) (“Russian Decree”); risks related to our potential inability to secure additional U.S. government waivers from the Import Ban Act in a timely manner or at all in order to allow us to continue importing Russian LEU under the TENEX Supply Contract or implementing the TENEX Supply Contract; risks related to TENEX’s refusal or its prohibition or inability to deliver, or timely deliver, LEU to us for any reason, including (i) U.S. or foreign government sanctions, bans, or decrees imposed on LEU from Russia or on TENEX, (ii) TENEX being unable, prohibited, or unwilling to receive payments, receive the return of natural uranium hexafluoride, or conduct other activities related to the TENEX Supply Contract, (iii) TENEX elects, or is directed (including by its owner or the Russian government), to limit, pause, or stop transactions with us or with the United States or other countries or (iv) TENEX is unable to secure specific export licenses from the Russian authorities as required by the Russian Decree for each shipment or secure them in a timely manner to ship Russian LEU to the United States, or such export licenses, once secured, are subsequently rescinded prior to shipment; risks related to laws, sanctions or other government measures that prohibit or restrict doing business with TENEX; risks related to disputes with third parties, including contractual counterparties, that could result if we do not receive timely deliveries of LEU under the TENEX Supply Contract and are unable to rely on contractual protections; risks related to our dependence on others, such as TENEX, under the TENEX Supply Contract, a subsidiary of Orano Cycle (“Orano”), under our long-term commercial supply agreement with Orano, and other suppliers (including, but not limited to, transporters, fabricators, or converters) who provide, or deliver, us the goods and services we need to conduct our business and any resulting negative impact on our liquidity; risks related to our ability to sell, transport or deliver the LEU we procure pursuant to our purchase obligations under our supply agreements and the impacts of sanctions or limitations on imports of such LEU, including those imposed under the 1992 Russian Suspension Agreement as amended, international trade legislation and other international trade restrictions including but not limited to the Import Ban Act and Russian Decree; risks related to the increasing quantities of LEU being imported into the United States from China and the impact on our ability to make future LEU or SWU sales or ability to finance any build out of our enrichment capacities; risk related to change in laws, tariffs or other government measures that would lift, lower or relax such laws, tariffs or government measures to allow the importation of LEU, or increase its cost, from Russia or other countries with restrictions; risks related to not being able to sell the Russian LEU we may be allowed to import in 2026 or 2027 for any reason, even if we secure waivers, including customers having filled their fuel needs for those years; risks related to whether or when government funding or demand for HALEU for government or commercial uses will materialize and at what level; risks regarding funding for continuation and deployment of the American Centrifuge technology; risks related to (i) our ability to perform and absorb costs under our agreement with the DOE to deploy and operate a cascade of centrifuges to demonstrate production of HALEU for advanced reactors (the “HALEU Operation Contract”), (ii) our ability to obtain new contracts and funding to be able to continue operations and (iii) our ability to obtain and/or perform under other agreements; risks that (i) we may not obtain the full benefit of the HALEU Operation Contract and may not be able or allowed to operate the HALEU enrichment facility to produce HALEU after the completion of the HALEU Operation Contract or (ii) the output from the HALEU enrichment facility may not be available to us as a future source of supply; risks related to existing or new trade barriers, and related to contract terms, that limit our ability to procure LEU for, or sell, transport, or deliver LEU to, customers; risks related to pricing trends and demand in the uranium and enrichment markets and their impact on our profitability; risks related to the movement and timing of customer orders; risks related to the fact that we face significant competition from major LEU producers who may be less cost sensitive or are wholly or partially government owned; risks that our ability to compete in foreign markets may be limited for various reasons, including policies that favor indigenous suppliers over foreign suppliers of goods and services; risks related to the fact that our revenue is largely dependent on our largest customers; risks related to our backlog, including uncertainty concerning customer actions under current contracts and in future contracting attributable to market conditions, global events or other factors, including our lack of current production capability; risks related to natural and other disasters, including the continued impact of the March 2011 earthquake and tsunami in Japan, on the nuclear industry and on our business, results of operations and prospects; risks related to financial difficulties experienced by customers or suppliers, including possible bankruptcies, insolvencies, or any other situation, event or occurrence that affect the ability of others to pay for our products or services in a timely manner or at all; risks related to pandemics, endemics, and other health crises; risks related to the impact and potential extended duration of a supply/demand imbalance in the market for LEU; risks related to DOE not issuing any major task orders to any contract awardee under any of the HALEU Production Contract, LEU Production Contract, or HALEU Deconversion Contract; risks related to the Company not winning a task order under the HALEU Production Contract, LEU Production Contract and HALEU Deconversion Contract to expand the capacity of the American Centrifuge plant; risks related to DOE not providing adequate share of the appropriated funding to the Company under any of the HALEU Production Contract, LEU Production Contract or HALEU Deconversion Contract; risks related to our ability to secure financing to expand our plant for LEU or HALEU or expand it to the level that would make it commercially viable; risks related to the DOE not exercising options following the completion of Phase 2 of the HALEU Operation Contract or awarding a third party to continue the HALEU Operation Contract; risks related to our inability to increase capacity for HALEU or LEU in a timely manner to meet market demand or our contractual obligations; risks related to DOE not awarding any contracts to the Company in response to the Company’s future proposals; risks related to reliance on the only firm that has the necessary permits and capability to transport LEU from Russia to the United States and that firm’s ability to maintain those permits and capabilities or secure additional permits; risks related to a government shutdown or lack of funding that could result in program cancellations, disruptions and/or stop work orders and could limit the U.S. government’s ability to make timely payments, including under Executive Order 14158, and our ability to perform our U.S. government contracts and successfully compete for work including under the HALEU Operation Contract; risks related to changes to the U.S. government’s appropriated funding levels for HALEU Operation Contract due to changes in U.S. government policy or other reasons; risks related to uncertainty regarding our ability to commercially deploy competitive enrichment technology; risks related to the potential for demobilization or termination of the HALEU Operation Contract; risks that we will not be able to timely complete the work that we are obligated to perform; risks related to the government’s inability to satisfy its obligations, including supplying government furnished equipment necessary for us to produce and deliver HALEU under the HALEU Operation Contract and processing security clearance applications resulting from a government shutdown or other reasons; risks related to our inability to obtain the government’s approval to extend the term of, or the scope of permitted activities under, our lease with the DOE in Piketon, Ohio; risks related to cybersecurity incidents that may impact our business operations; risks related to our inability to perform fixed-price and cost-share contracts such as the HALEU Operation Contract, including the risk that costs that we must bear could be higher than expected and the risk related to complying with stringent government contractual requirements; risks related to our inability to attract qualified employees necessary for the potential expansion of our operations in Oak Ridge, Tennessee or Piketon, Ohio; risks related to our long-term liabilities, including our defined benefit pension plan obligations and postretirement health and life benefit obligations; risks related to our 2.25% Convertible Senior Notes maturing in 2030; risks of revenue and operating results fluctuating significantly from quarter to quarter, and in some cases, year to year; risks related to the impact of financial market conditions on our business, liquidity, prospects, pension assets and insurance facilities; risks related to the Company’s capital concentration; risks related to the value of our intangible assets related to LEU segment’s backlog and customer relationships; risks related to decisions made by our Class B Common Stock stockholders regarding their investment in the Company, including decisions based upon factors that are unrelated to the Company’s performance; risks that a small number of holders of our Class A Common Stock (whose interests may not be aligned with other holders of our Class A Common Stock) may exert significant influence over the direction of the Company and may be motivated by interests that are not aligned with the Company’s other Class A stockholders; risks related to (i) the use of our net operating losses (“NOLs”) carryforwards and net unrealized built-in losses (“NUBILs”) to offset future taxable income and the use of the Rights Agreement, dated as of April 6, 2016 to prevent an “ownership change” as defined in Section 382 of the Internal Revenue Code of 1986, as amended (the “Code”) and (ii) our ability to generate taxable income to utilize all or a portion of the NOLs prior to the expiration thereof and NUBILs; risks related to failures or security, including cybersecurity, breaches of our information technology systems; risks related to our ability to attract and retain key personnel; risks that we will be unable to obtain new business opportunities or achieve market acceptance of our products and services or that products or services provided by others will render our products or services obsolete or noncompetitive; risks related to actions, including investigations, reviews or audits, that may be taken by the U.S. government, the Russian government, or other governments that could affect our ability to perform under our contractual obligations or the ability of our sources of supply to perform under their contractual obligations to us; risks related to our inability to perform and receive timely payment under our agreements with the DOE or other government agencies, including risks related to the ongoing funding by the government and potential audits; risks related to how aligned we may be, or perceived to be, with any political party, administration, or its policies based on our positions or our political action committee’s advocacy; risks related to changes or termination of our agreements with the U.S. government or other counterparties, or the exercise of contract remedies by such counterparties; risks related to the competitive environment for our products and services; risks related to changes in the nuclear energy industry; risks related to the competitive bidding process associated with obtaining contracts, including government contracts; risks related to potential strategic transactions that could be difficult to implement, that could disrupt our business or that could change our business profile significantly; risks related to the outcome of legal proceedings and other contingencies (including lawsuits and government investigations or audits); risks related to the impact of, or changes to, government regulation and policies or interpretation of laws or regulations, including by the U.S. Securities and Exchange Commission, the DOE, the U.S. Department of Commerce and the U.S. Nuclear Regulatory Commission; risks related to the recent U.S. federal government administration’s reliance on executive orders to implement regulatory or trade policy and objectives, which could exacerbate regulatory or, private or public, financing unpredictability; risks of accidents during the transportation, handling, or processing of toxic hazardous or radioactive material that may pose a health risk to humans or animals, cause property or environmental damage, or result in precautionary evacuations, and lead to claims against the Company; risks associated with claims and litigation arising from past activities at sites we currently operate or past activities at sites that we no longer operate, including the Paducah, Kentucky, and Portsmouth, Ohio, gaseous diffusion plants; and other risks discussed in this news release and in our filings with the SEC

Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. These factors may not constitute all factors that could cause actual results to differ from those discussed in any forward-looking statement. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. Readers are urged to carefully review and consider the various disclosures made in this news release and in our filings with the SEC, including our Annual Report on Form 10-K for the year ended December 31, 2024, under Part II, Item 1A – “Risk Factors” in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, and in our filings with the SEC that attempt to advise interested parties of the risks and factors that may affect our business. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.

Contacts:

Media: Dan Leistikow at [email protected]
Investors: Neal Nagarajan at [email protected] 

 


CENTRUS ENERGY CORP.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

(Unaudited; in millions, except share and per share data)



Three Months Ended

March 31,


2025


2024

Revenue:

Separative work units

$                        51.3

$                        23.6

Uranium

Technical solutions

21.8

20.1

Total revenue

73.1

43.7

Cost of Sales:

Separative work units and uranium

20.1

23.1

Technical solutions

20.1

16.3

Total cost of sales

40.2

39.4

Gross profit

32.9

4.3

Advanced technology costs

3.0

5.7

Selling, general and administrative

8.3

8.1

Amortization of intangible assets

1.1

1.1

Operating income (loss)

20.5

(10.6)

Nonoperating components of net periodic benefit loss

0.9

0.1

Interest expense

3.4

0.4

Investment income

(7.3)

(2.8)

Extinguishment of long-term debt

(11.8)

Other expense, net

0.1

0.1

Income (loss) before income taxes

35.2

(8.4)

Income tax expense (benefit)

8.0

(2.3)

Net income (loss) and comprehensive income (loss)

$                        27.2

$                        (6.1)

Net income (loss) per share:

   Basic

$                        1.60

$                      (0.38)

   Diluted

$                        1.60

$                      (0.38)

Average number of common shares outstanding (in thousands):

   Basic

16,982

15,906

   Diluted

17,048

15,906

 


CENTRUS ENERGY CORP.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited; in millions)



Three Months Ended

March 31,


2025


2024


OPERATING

Net income

$             27.2

$             (6.1)

Adjustments to reconcile net income to cash used in operating activities:

Depreciation and amortization

1.5

1.3

Deferred tax assets

7.5

(2.1)

Equity related compensation

0.5

0.2

Revaluation of inventory borrowings

2.1

0.3

Gain on extinguishment of 8.25% Notes

(11.8)

Other reconciling adjustments, net

0.6

0.1

Changes in operating assets and liabilities:

Accounts receivable

41.3

29.5

Inventories

(268.1)

27.2

Inventories owed to customers and suppliers

187.7

(62.7)

Other current assets

0.8

(0.8)

Accounts payable and other liabilities

(6.2)

(5.1)

Payables under inventory purchase agreements

55.6

25.7

Deferred revenue and advances from customers, net of deferred costs

0.1

0.4

Pension and postretirement benefit liabilities

(2.2)

(2.6)

Other changes, net

(0.1)

Cash provided by operating activities

36.5

5.3


INVESTING

Capital expenditures

(2.1)

(1.5)

Cash used in investing activities

(2.1)

(1.5)


FINANCING

Proceeds from the issuance of common stock, net

25.2

7.1

Exercise of stock options

0.4

Payment of interest classified as debt

(3.5)

(3.1)

Payment of principal to redeem 8.25% Notes

(74.3)

Cash provided by (used in) financing activities

(52.6)

4.4

Effect of exchange rate changes on cash, cash equivalents and restricted cash

(0.1)

(0.1)

Increase (decrease) in cash, cash equivalents and restricted cash

(18.3)

8.1

Cash, cash equivalents and restricted cash, beginning of period

704.0

233.8

Cash, cash equivalents and restricted cash, end of period

$           685.7

$           241.9

Non-cash activities:

Property, plant and equipment included in accounts payable and accrued liabilities

$               0.2

$               0.1

Equity issuance costs included in accounts payable and accrued liabilities

$                —

$               0.3

Common stock withheld for tax obligations under stock-based compensation plan

$               0.3

$                —

 


CENTRUS ENERGY CORP.

CONSOLIDATED BALANCE SHEETS

(Unaudited; in millions, except share and per share data)



March 31, 

 2025


December 31, 

 2024


ASSETS

Current assets:

Cash and cash equivalents

$                   653.0

$                   671.4

Accounts receivable

38.7

80.0

Inventories

429.6

161.6

Deferred costs associated with deferred revenue

63.9

63.9

Other current assets

37.5

38.3

Total current assets

1,222.7

1,015.2

Property, plant and equipment, net of accumulated depreciation of $5.5 million and $5.3
     million as of March 31, 2025 and December 31, 2024, respectively

11.2

9.4

Deposits for financial assurance

2.7

2.6

Intangible assets, net

28.5

29.6

Deferred tax assets

21.8

29.3

Other long-term assets

7.0

7.3

Total assets

$                1,293.9

$                1,093.4


LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

Accounts payable and accrued liabilities

$                     32.5

$                     38.8

Payables under inventory purchase agreements

85.1

29.5

Inventories owed to customers and suppliers

203.9

16.2

Deferred revenue and advances from customers

216.5

216.4

Short-term inventory loans

39.8

39.8

Current debt

6.1

Total current liabilities

577.8

346.8

Long-term debt

389.5

472.5

Postretirement health and life benefit obligations

72.5

74.6

Pension benefit liabilities

3.9

4.0

Long-term inventory loans

28.3

26.2

Other long-term liabilities

8.0

7.9

Total liabilities

1,080.0

932.0

Stockholders’ equity:

Preferred stock, par value $1.00 per share, 20,000,000 shares authorized

Series A Participating Cumulative Preferred Stock, none issued

Series B Senior Preferred Stock, none issued

Class A Common Stock, par value $0.10 per share, 70,000,000 shares authorized,
     16,316,821 and 16,045,916 shares issued and outstanding as of March 31, 2025 and
      December 31, 2024, respectively

1.6

1.6

Class B Common Stock, par value $0.10 per share, 30,000,000 shares authorized, 719,200
      shares issued and outstanding as of March 31, 2025 and December 31, 2024

0.1

0.1

Excess of capital over par value

261.9

236.5

Accumulated deficit

(49.1)

(76.3)

Accumulated other comprehensive loss

(0.6)

(0.5)

Total stockholders’ equity

213.9

161.4

Total liabilities and stockholders’ equity

$                1,293.9

$                1,093.4

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/centrus-reports-first-quarter-2025-results-302449247.html

SOURCE Centrus Energy Corp.

Osisko Reports Q1 2025 Results

Strong Cash Flows of $46.1 Million from Operating Activities

MONTRÉAL, May 07, 2025 (GLOBE NEWSWIRE) — Osisko Gold Royalties Ltd (the “Company” or “Osisko”) (OR: TSX & NYSE) today announced its consolidated financial results for the first quarter of 2025. Amounts presented are in United States dollars, except where otherwise noted.

Highlights

  • 19,014 gold equivalent ounces (“GEOs”1) earned (22,259 GEOs in Q1 20242); 
  • Revenues from royalties and streams of $54.9 million ($45.0 million in Q1 2024); 
  • Cash flows generated by operating activities of $46.1 million ($37.4 million in Q1 2024); 
  • Quarterly cash margin3 of $53.3 million or 97.1% ($43.7 million or 97.0% in Q1 2024); 
  • Net earnings of $25.6 million, $0.14 per basic share ($11.2 million, $0.06 per basic share in Q1 2024); 
  • Adjusted earnings3 of $29.5 million, $0.16 per basic share ($22.0 million, $0.12 per basic share in Q1 2024); 
  • Net repayment of $19.6 million under the revolving credit facility;  
  • Cash balance of $63.1 million and debt of $74.3 million as at March 31, 2025; 
  • Acquisition of a 1.5% net smelter return (“NSR”) royalty from Japan Gold Corp. (“Japan Gold”) on Japan Gold’s wholly-controlled properties in Japan for cash consideration of $5.0 million; and
  • Declaration of a quarterly dividend of C$0.065 per common share paid on April 15, 2025 to shareholders of record as of the close of business on March 31, 2025.

Subsequent to March 31, 2025

  • Additional repayments of $30.0 million under the Company’s revolving credit facility; 
  • First payment received from Talisker Resources Ltd. under the Bralorne 1.7% NSR royalty; 
  • Acquisition of a basket of royalties across various projects in British Columbia from Sable Resources Ltd. (“Sable Resources”) for consideration of C$3.8 million, as well as certain rights in relation to the future acquisition of similar interests from Sable Resources; 
  • Publication of the fifth edition of the Company’s sustainability report, Growing Responsibly; and
  • Declaration of a quarterly dividend of US$0.055 per common share, a 20% increase over the previous quarterly dividend, based on the foreign exchange rate (C$/US$) on the declaration date of the first quarter dividend. The dividend will be paid on July 15, 2025 to shareholders of record as of the close of business on June 30, 2025.  

Management Commentary

Jason Attew, President & CEO of Osisko commented: “Osisko’s first quarter represented a good start for the Company in 2025 and serves as a solid base for Osisko to achieve its 2025 guidance range of 80,000 to 88,000 GEOs earned, especially considering that the Company’s GEO deliveries are expected to sequentially improve quarter-by-quarter throughout the remainder of the year ahead.

Looking ahead over the next few months, there are several upcoming catalysts to watch out for, including, but not limited to, Osisko Development’s project financing initiatives on the back of last week’s Optimized Feasibility Study results for the fully-permitted Cariboo gold project; a new life-of-mine plan at Alamos Gold’s Island Gold District; and finally, the anticipated Implementation of the Scheme of Arrangement between Spartan Resources and Ramelius Resources, which, if implemented, could accelerate first production from Dalgaranga to late 2025, a full year ahead of Osisko’s expectations when we acquired the Dalgaranga 1.8% gross smelter return royalty in late September of 2024.”

Norman MacDonald, Board Chair of Osisko, also commented: “Tomorrow’s Annual and Special Meeting of Shareholders will mark the end of Joanne Ferstman’s tenure as an Independent Director on Osisko’s Board. Joanne has been on Osisko’s Board of Directors from the very beginning, and, as such, both Board and Management would like to wholeheartedly thank Joanne for her many years of leadership, guidance and service. Her attention to detail and dedication to realizing the Company’s strategic vision, amongst her many other skills, will be missed. We would also like to wish Joanne all the best in her future endeavours.”

Q1 2025 RESULTS CONFERENCE AND WEBCAST CALL DETAILS

Conference Call: Thursday, May 8th, 2025 at 10:00 am ET
   
Dial-in Numbers:
(Option 1)
North American Toll-Free:  1 (800) 717-1738
Local – Montreal: 1 (514) 400-3792
Local – Toronto: 1 (289) 514-5100
Local – New York: 1 (646) 307-1865
Conference ID: 33088
   
Webcast link:
(Option 2)
https://viavid.webcasts.com/starthere.jsp?ei=1713958&tp_key=482b1aae4e
   
Replay (available until
Sunday, June 8th, at 11:59
PM ET):
North American Toll-Free: 1 (888) 660-6264
Local – Toronto: 1 (289) 819-1325
Local – New York: 1 (646) 517-3975
Playback Passcode: 33088#
   
  Replay also available on our website at www.osiskogr.com
   

Annual and Special Meeting of Shareholders

The Company’s 2025 Annual and Special Meeting of shareholders will be held on May 8, 2025 in Montréal, Québec.

Qualified Person

The scientific and technical content of this news release has been reviewed and approved by Guy Desharnais, Ph.D., P.Geo., Vice President, Project Evaluation at Osisko Gold Royalties Ltd, who is a “qualified person” as defined by National Instrument 43-101 – Standards of Disclosure for Mineral Projects (“NI 43-101”).

About Osisko Gold Royalties Ltd

Osisko Gold Royalties Ltd is an intermediate precious metal royalty company which holds a North American focused portfolio of over 195 royalties, streams and precious metal offtakes, including 21 producing assets. Osisko’s portfolio is anchored by its cornerstone asset, a 3-5% net smelter return royalty on the Canadian Malartic Complex, home to one of Canada’s largest gold mines. 

Osisko’s head office is located at 1100 Avenue des Canadiens-de-Montréal, Suite 300, Montréal, Québec, H3B 2S2.

For further information, please contact Osisko Gold Royalties Ltd:
Grant Moenting
Vice President, Capital Markets
Tel: (514) 940-0670 x116
Cell: (365) 275-1954
Email: [email protected]
Heather Taylor
Vice President, Sustainability and Communications
Tel: (514) 940-0670 x105
Email: [email protected]
   

Notes:
(1) Gold Equivalent Ounces

GEOs are calculated on a quarterly basis and include royalties and streams. Silver ounces and copper tonnes earned from royalty and stream agreements are converted to gold equivalent ounces by multiplying the silver ounces or copper tonnes by the average silver price per ounce or copper price per tonne for the period and dividing by the average gold price per ounce for the period. Diamonds, other metals and cash royalties are converted into gold equivalent ounces by dividing the associated revenue by the average gold price per ounce for the period.

 

  Average Metal Prices and Exchange Rate  
     
    Three months ended
March 31,
 
      2025       2024  
             
  Gold (i) $ 2,860     $ 2,070  
  Silver (ii) $ 31.88     $ 23.34  
  Copper (iii) $ 9,340     $ 8,438  
       
  Exchange rate (C$/US$) (iv)   0.6968       0.7415  

 

  (i) The average price represents the London Bullion Market Association’s PM price in U.S. dollars per ounce.
  (ii) The average price represents the London Bullion Market Association’s price in U.S. dollars per ounce.
  (iii) The average price represents the London Metal Exchange’s price in U.S. dollars per tonne.
  (iv) Bank of Canada daily rate.

 

(2) Three months ended March 31, 2024 (“Q1 2024”).
   
(3) Non-IFRS Measures

Cash margin 
  
Cash margin in dollars and in percentage of revenues are non-IFRS financial measures. Cash margin (in dollars) is defined by Osisko as revenues less cost of sales (excluding depletion). Cash margin (in percentage of revenues) is obtained from the cash margin (in dollars) divided by revenues.  
  
Management uses cash margin in dollars and in percentage of revenues to evaluate Osisko’s ability to generate positive cash flow from its royalty, stream and other interests. Management and certain investors also use this information, together with measures determined in accordance with IFRS Accounting Standards such as gross margin and operating cash flows, to evaluate Osisko’s performance relative to peers in the mining industry who present these measures on a similar basis. Cash margin in dollars and in percentage of revenues are only intended to provide additional information to investors and analysts and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS Accounting Standards. They do not have any standardized meaning under IFRS Accounting Standards and may not be comparable to similar measures presented by other issuers.  

A reconciliation of the cash margin per type of interests (in thousands of dollars and in percentage of revenues) is presented below:

 

    Three months ended

March 31,


 
    2025     2024  
    $     $  
             
 
Royalty interests
         
  Revenues 36,790     33,029  
  Less: cost of sales (excluding depletion) (145 )   (78 )
  Cash margin (in dollars) 36,645     32,951  
         
  Depletion (2,710 )   (4,104 )
  Gross profit 33,935     28,847  
         
 
Stream interests
     
  Revenues 18,126     12,018  
  Less: cost of sales (excluding depletion) (1,474 )   (1,281 )
  Cash margin (in dollars) 16,652     10,737  
         
  Depletion (5,034 )   (4,442 )
  Gross profit 11,618     6,295  
         
 
Royalty and stream interests


Total cash margin (in dollars)
53,297     43,688  
  Divided by: total revenues 54,916     45,047  
  Cash margin (in percentage of revenues) 97.1 %   97.0 %
         
  Total – Gross profit 45,553     35,142  

 

  Adjusted earnings and adjusted earnings per basic share

Adjusted earnings and adjusted earnings per basic share are non-IFRS financial measures and are defined by Osisko by excluding the following items from net earnings (loss) and earnings (loss) per share: foreign exchange gains (losses), impairment charges and reversal related to royalty, stream and other interests, changes in allowance for expected credit losses, write-offs and impairment of investments, gains (losses) on disposal of assets, gains (losses) on investments, share of income (loss) of associates, transaction costs and other items such as non-cash gains (losses), as well as the impact of income taxes on these items. Adjusted earnings per basic share is obtained from the adjusted earnings divided by the weighted average number of common shares outstanding for the period.

Management uses adjusted earnings and adjusted earnings per basic share to evaluate the underlying operating performance of Osisko as a whole for the reporting periods presented, to assist with the planning and forecasting of future operating results, and to supplement information in its consolidated financial statements. Management believes that in addition to measures prepared in accordance with IFRS Accounting Standards such as net earnings (loss) and net earnings (loss) per basic share, investors and analysts use adjusted earnings and adjusted earnings per basic share to evaluate the results of the underlying business of Osisko, particularly since the excluded items are typically not included in Osisko’s annual guidance. While the adjustments to net earnings (loss) and net earnings (loss) per basic share in these measures include items that are both recurring and non-recurring, management believes that adjusted earnings and adjusted net earnings per basic share are useful measures of Osisko’s performance because they adjust for items which may not relate to or have a disproportionate effect on the period in which they are recognized, impact the comparability of the core operating results from period to period, are not always reflective of the underlying operating performance of the business and/or are not necessarily indicative of future operating results. Adjusted net earnings and adjusted net earnings per basic share are intended to provide additional information to investors and analysts and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS Accounting Standards. They do not have any standardized meaning under IFRS Accounting Standards and may not be comparable to similar measures presented by other issuers.

A reconciliation of net earnings to adjusted net earnings is presented below:

 

    Three months ended

March 31,


 
    2025     2024  
  (in thousands of dollars,

except per share amounts)
$     $  
             
  Net earnings 25,640     11,169  
             
  Adjustments:          
  Foreign exchange (gain) loss (160 )   2,411  
  Share of loss of associates 3,752     10,053  
  Changes in allowance for expected credit losses and write-offs     (1,399 )
  Loss (gain) on investments 286     (388 )
  Tax impact of adjustments (41 )   136  
             
  Adjusted earnings 29,477     22,032  
             
  Weighted average number of common shares outstanding (000’s) 186,979     185,761  
             
  Adjusted earnings per basic share 0.16     0.12  
             


Forward-Looking Statements  

Certain statements contained in this press release may be deemed “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking statements are statements other than statements of historical fact, that address, without limitation, future events, that Osisko will meet its guidance estimate, that development and milestones to be achieved by operators of the properties in which the Company holds interest will be achieved in a timely manner. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words “expects”, “plans”, “anticipates”, “believes”, “intends”, “estimates”, “projects”, “potential”, “scheduled” and similar expressions or variations (including negative variations), or that events or conditions “will”, “would”, “may”, “could” or “should” occur. Forward-looking statements are subject to known and unknown risks, uncertainties and other factors, most of which are beyond the control of Osisko, and actual results may accordingly differ materially from those in forward-looking statements. Such risk factors include, without limitation, (i) with respect to properties in which Osisko holds a royalty, stream or other interest; risks related to: (a) the operators of the properties, (b) timely development, permitting, construction, commencement of production, ramp-up (including operating and technical challenges), (c) differences in rate and timing of production from resource estimates or production forecasts by operators, (d) differences in conversion rate from resources to reserves and ability to replace resources, (e) the unfavorable outcome of any challenges or litigation relating title, permit or license, (f) hazards and uncertainty associated with the business of exploring, development and mining including, but not limited to unusual or unexpected geological and metallurgical conditions, slope failures or cave-ins, flooding and other natural disasters or civil unrest or other uninsured risks, (ii) with respect to other external factors: (a) fluctuations in the prices of the commodities that drive royalties, streams, offtakes and investments held by Osisko, (b) a trade war or new tariff barriers, (c) fluctuations in the value of the Canadian dollar relative to the U.S. dollar, (d) regulatory changes by national and local governments, including permitting and licensing regimes and taxation policies, regulations and political or economic developments in any of the countries where properties in which Osisko holds a royalty, stream or other interest are located or through which they are held, (e) continued availability of capital and financing and general economic, market or business conditions, and (f) responses of relevant governments to infectious diseases outbreaks and the effectiveness of such response and the potential impact of such outbreaks on Osisko’s business, operations and financial condition; (iii) with respect to internal factors: (a) business opportunities that may or not become available to, or are pursued by Osisko, (b) the integration of acquired assets or (c) the determination of Osisko’s PFIC status (d) that preliminary financial information may be subject to quarter end adjustments. The forward-looking statements contained in this press release are based upon assumptions management believes to be reasonable, including, without limitation: the absence of significant change in Osisko’s ongoing income and assets relating to determination of its PFIC status, and the absence of any other factors that could cause actions, events or results to differ from those anticipated, estimated or intended and, with respect to properties in which Osisko holds a royalty, stream or other interest, (i) the ongoing operation of the properties by the owners or operators of such properties in a manner consistent with past practice and with public disclosure (including forecast of production), (ii) the accuracy of public statements and disclosures made by the owners or operators of such underlying properties (including expectations for the development of underlying properties that are not yet in production), (iii) no adverse development in respect of any significant property, (iv) that statements and estimates relating to mineral reserves and resources by owners and operators are accurate and (v) the implementation of an adequate plan for integration of acquired assets.

For additional information on risks, uncertainties and assumptions, please refer to the most recent Annual Information Form of Osisko filed on SEDAR+ at

www.sedarplus.ca

and EDGAR at

www.sec.gov

which also provides additional general assumptions in connection with these statements. Osisko cautions that the foregoing list of risk and uncertainties is not exhaustive. Investors and others should carefully consider the above factors as well as the uncertainties they represent and the risk they entail. Osisko believes that the assumptions reflected in those forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be accurate as actual results and prospective events could materially differ from those anticipated such the forward-looking statements and such forward-looking statements included in this press release are not guarantee of future performance and should not be unduly relied upon. In this press release, Osisko relies on information publicly disclosed by other issuers and third parties pertaining to its assets and, therefore, assumes no liability for such third-party public disclosure. These statements speak only as of the date of this press release. Osisko undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, other than as required by applicable law.

Osisko Gold Royalties Ltd

Consolidated Balance Sheets
As at March 31, 2025 and December 31, 2024
(Unaudited)
(tabular amounts expressed in thousands of United States dollars)
           
  March 31,     December 31,  
  2025     2024  
  $     $  
           
Assets          
           
Current assets          
           
Cash 63,070     59,096  
Amounts receivable 2,773     3,106  
Other assets 1,511     1,612  
  67,354     63,814  
           
Non-current assets          
           
Investments in associates 40,086     43,262  
Other investments 85,403     74,043  
Royalty, stream and other interests 1,112,393     1,113,855  
Goodwill 77,353     77,284  
Other assets 6,140     5,376  
  1,388,729     1,377,634  
           
Liabilities          
           
Current liabilities          
           
Accounts payable and accrued liabilities 3,923     5,331  
Dividends payable 8,457     8,433  
Lease liabilities 1,132     852  
  13,512     14,616  
           
Non-current liabilities          
           
Lease liabilities 4,539     3,931  
Long-term debt 74,346     93,900  
Deferred income taxes 82,438     76,234  
  174,835     188,681  
           
Equity           
           
Share capital 1,680,514     1,675,940  
Contributed surplus 65,003     63,567  
Accumulated other comprehensive loss (139,637 )   (141,841 )
Deficit (391,986 )   (408,713 )
  1,213,894     1,188,953  
  1,388,729     1,377,634  
           

 

Osisko Gold Royalties Ltd

Consolidated Statements of Income
For the three months ended March 31, 2025 and 2024
(Unaudited)
(tabular amounts expressed in thousands of United States dollars, except per share amounts)
           
  2025     2024  
  $     $  
      (restated)  
Revenues 54,916     45,047  
       
Cost of sales (1,619 )   (1,359 )
Depletion (7,744 )   (8,546 )
Gross profit 45,553     35,142  
       
Other operating expenses      
General and administrative (4,959 )   (4,544 )
Business development (2,079 )   (1,011 )
Operating income 38,515     29,587  
Interest income 598     934  
Finance costs (1,730 )   (2,767 )
Foreign exchange gain (loss) 160     (2,411 )
Share of loss of associates (3,752 )   (10,053 )
Other (losses) gains, net (286 )   1,737  
Earnings before income taxes 33,505     17,027  
Income tax expense (7,865 )   (5,858 )
Net earnings 25,640     11,169  
       
Net earnings per share      
Basic and diluted 0.14     0.06  
       

 

Osisko Gold Royalties Ltd

Consolidated Statements of Cash Flows
For the three months ended March 31, 2025 and 2024
(Unaudited)
(tabular amounts expressed in thousands of United States dollars)
   
  2025     2024  
  $     $  
        (restated)  
Operating activities      
Net earnings 25,640     11,169  
Adjustments for:      
Share-based compensation 2,089     1,567  
Depletion and amortization 8,032     8,790  
Changes in expected credit loss of other investments     (1,399 )
Share of loss of associates 3,752     10,053  
Change in fair value of financial assets at fair value through profit and loss 286     (338 )
Foreign exchange (gain) loss (92 )   2,437  
Deferred income tax expense 7,242     5,463  
Other 104     116  
Net cash flows provided by operating activities
before changes in non-cash working capital items
47,053     37,858  
Changes in non-cash working capital items (974 )   (496 )
Net cash flows provided by operating activities 46,079     37,362  
       
Investing activities      
Acquisitions of short-term investments     (667 )
Acquisitions of investments (11,364 )    
Proceeds from disposal of investments     3,847  
Acquisitions of royalty and stream interests (5,285 )    
Other (17 )   (3 )
Net cash flows (used in) provided by investing activities (16,666 )   3,177  
       
Financing activities      
Increase in long-term debt 10,437      
Repayment of long-term debt (30,000 )   (32,394 )
Exercise of share options and shares issued under the share purchase plan 2,587     3,609  
Dividends paid (7,610 )   (7,680 )
Withholding taxes on settlement of restricted and deferred share units (653 )   (2,204 )
Other (210 )   (288 )
Net cash flows used in financing activities (25,449 )   (38,957 )
       
Increase in cash before effects of exchange rate changes 3,964     1,582  
Effects of exchange rate changes on cash 10     (682 )
Net increase in cash 3,974     900  
Cash – beginning of period 59,096     51,204  
Cash – end of period 63,070     52,104  
           



Western Digital Names Finance Executive Kris Sennesael as Chief Financial Officer

Western Digital Names Finance Executive Kris Sennesael as Chief Financial Officer

SAN JOSE, Calif.–(BUSINESS WIRE)–
Western Digital (Nasdaq: WDC) announced today that it has hired Kris Sennesael as Chief Financial Officer (CFO) effective May 12, 2025. With more than 25 years of experience in finance and general management across the semiconductor and technology industries, Sennesael most recently served as CFO at Skyworks Solutions.

“I am excited for Kris to join Western Digital. His tenure of being a hands-on leader and experience across all global markets will further strengthen our position moving forward,” said Irving Tan, Western Digital’s Chief Executive Officer. “I’m looking forward to his expertise and leadership as we build the future of Western Digital together, balancing investment for innovation and growth with operational efficiency to create sustainable, long-term shareholder value.”

Sennesael will report directly to Tan and will lead Western Digital’s global finance organization including finance, accounting, financial reporting, tax, treasury, internal audit, corporate real estate, and investor relations.

In his prior role with Skyworks Solutions, Sennesael collaborated extensively with the Board of Directors, CEO, and the executive team to steer strategic initiatives aimed at creating shareholder value, and contributed to scaling the business through both organic and inorganic growth strategies. Prior to this role, he held the CFO position at both Enphase Energy and Standard Microsystems, and held leadership roles at ON Semiconductor, AMI Semiconductor, and Alcatel Microelectronics.

About Western Digital

Western Digital empowers the systems and people who rely on data. Consistently delivering massive capacity, high quality and low TCO, Western Digital is trusted by hyperscale cloud providers, enterprise data centers, content professionals and consumers around the world. Core to its values, the company recognizes the urgency to combat climate change and is on a mission to design storage technologies that not only meet today’s data demands but also contribute to a more climate-conscious future. Follow Western Digital on LinkedIn and learn more at http://www.westerndigital.com/.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of federal securities laws, including statements regarding expectations for: the company’s future position and creation of shareholder value. These forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements. Key risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements include: adverse global or regional conditions, including new or additional tariffs or trade restrictions; volatility in demand for the company’s products; inflation; increases in interest rates and an economic recession; future responses to and effects of global health crises; the impact of business and market conditions; the outcome and impact of the company’s completed separation of the HDD and Flash businesses, including with respect to stock price volatility and the diversion of management’s attention from ongoing business operations and opportunities; the impact of competitive products and pricing; the company’s development and introduction of products based on new technologies and expansion into new data storage markets; risks associated with cost saving initiatives, restructurings, acquisitions, divestitures, mergers, joint ventures and the company’s strategic relationships; difficulties or delays in manufacturing or other supply chain disruptions; hiring and retention of key employees; the company’s level of debt and other financial obligations; changes to the company’s relationships with key customers; compromise, damage or interruption from cybersecurity incidents or other data system security risks; actions by competitors; any decisions to reduce or discontinue paying cash dividends; the company’s ability to achieve its greenhouse gas emissions reduction and other sustainability goals; the impact of international conflicts; risks associated with compliance with changing legal and regulatory requirements and the outcome of legal proceedings; and other risks and uncertainties listed in the company’s filings with the Securities and Exchange Commission (the “SEC”), including the company’s Annual Report on Form 10-K filed with the SEC on August 20, 2024 and Quarterly Report on Form 10-Q filed with the SEC on May 2, 2025, to which your attention is directed. You should not place undue reliance on these forward-looking statements, which speak only as of the date hereof, and we undertake no obligation to update or revise these forward-looking statements to reflect new information or events, except as required by law.

© 2025 Western Digital Corporation or its affiliates. All rights reserved. Western Digital, the Western Digital design, and the Western Digital logo are registered trademarks or trademarks of Western Digital Corporation or its affiliates in the US and/or other countries. All other marks are the property of their respective owners.

Western Digital Media Relations

[email protected]

Western Digital Investor Relations

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Technology Hardware Semiconductor Data Management

MEDIA:

Logo
Logo

Myomo Reports First Quarter 2025 Financial and Operating Results

Myomo Reports First Quarter 2025 Financial and Operating Results

Revenue of $9.8 million

Record 700 patients added to the pipeline

More than 300 Certified Prosthetists Orthotists have completed initial MyoPro® training

Conference call being held today at 4:30pm Eastern time

BURLINGTON, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three months ended March 31, 2025.

Financial and operating highlights for the first quarter of 2025 include the following (all comparisons are with the first quarter of 2024 unless otherwise indicated):

  • Revenue was $9.8 million, up 162%;
  • Revenue units were 182, up 100%; 45% of revenue units were from first quarter authorizations and orders
  • Medicare Part B patients represented 59% of first quarter 2025 revenue;
  • Orders and insurance authorizations were received for 213 MyoPro units, up 18%;
  • Backlog, which represents insurance authorizations and orders received but not yet converted to revenue, was 249 units as of March 31, 2025, down 9%;
  • A record 700 new candidates were added to the patient pipeline, up 42%;
  • There were 1,482 MyoPro candidates in the patient pipeline as of March 31, 2025, up 33%;
  • Gross margin was 67.2%, up 600 basis points;
  • Cost per pipeline add was $2,300, up 31%; and
  • Initial training of more than 300 certified prosthetist orthotists (“CPO’s”) was completed as of March 31, 2025. MyoPro certification classes now underway.

Management Commentary

“Our first quarter financial results were in line with expectations, yet several operating metrics were affected by continued utilization management by Medicare Advantage plans which impacted authorizations and orders, as well as changes to social media algorithms that disrupted lead flow and increased our cost per pipeline add during the first six weeks of the quarter. I’m pleased to report that both lead flow and pipeline adds rebounded in March and April,” said Paul R. Gudonis, Myomo’s Chairman and Chief Executive Officer.

Financial Results

 

For the Three Months

Ended March 31,

 

Period-

to-Period

Change

 

 

2025

 

2024

 

$

 

%

 

Product revenue

$

9,831,814

 

$

3,754,389

 

$

6,077,425

 

 

162

%

Cost of revenue

 

3,222,184

 

 

1,455,345

 

 

1,766,839

 

 

121

%

Gross profit

$

6,609,630

 

$

2,299,044

 

$

4,310,586

 

 

187

%

Gross margin %

 

67.2

%

 

61.2

%

 

 

 

6.0

%

Revenue for the first quarter of 2025 was $9.8 million, up 162% compared with the first quarter of 2024, driven by an increase in the number of revenue units and by a higher average selling price (“ASP”). First quarter 2024 revenues included very few Medicare patients as CMS fees for the MyoPro became effective in April 2024. Myomo recognized revenue on 182 MyoPro units in the first quarter of 2025, up 100% over the same quarter a year ago. ASP was approximately $54,000 in the first quarter, up 31% over the same period a year ago. Revenue from patients with Medicare Part B represented 59% of first quarter 2025 revenue. First quarter revenue was the Company’s highest velocity revenue, with 45% of revenue generated from authorizations and orders received during the quarter.

Gross margin for the first quarter of 2025 was 67.2%, compared with 61.2% for the first quarter of 2024. The increase was driven primarily by a higher ASP and higher fixed overhead absorbed into inventory.

Operating expenses for the first quarter of 2025 were $10.1 million, an increase of 64% compared with the first quarter of 2024. The increase was primarily due to higher payroll expense, reflecting higher headcount to support expected growth in the direct billing channel, increased engineering activity resulting in higher research and development spending and higher advertising expenditures. Advertising costs of $1.6 million were up 104% over the first quarter of 2024. Social media algorithm changes resulted in a cost per pipeline add of $2,300, an increase of 31% compared with the first quarter of 2024.

Operating loss for the first quarter of 2025 was $3.5 million, compared with an operating loss of $3.9 million for the first quarter of 2024. Net loss for the first quarter of 2025 was $3.5 million, or $0.08 per share, compared with a net loss of $3.8 million, or $0.10 per share, for the first quarter of 2024.

Adjusted EBITDA for the first quarter of 2025 was $(2.8) million, compared with Adjusted EBITDA of $(3.5) million for the first quarter of 2024. A reconciliation of GAAP net loss to this non-GAAP financial measure appears below.

Operations Update

The MyoPro patient pipeline was 1,482 patients as of March 31, 2025, compared with 1,112 patients as of March 31, 2024, an increase of 33%. Despite temporary lead generation challenges, a record 700 medically-qualified patients were added to the pipeline during the first quarter of 2025, an increase of 42% compared with the same period a year ago. The Company generated 213 MyoPro authorizations and orders in the first quarter of 2025, an increase of 18% compared with the same period a year ago. Higher velocity of revenue affected the ending backlog, which was 249 patients as of March 31, 2025, a decrease of 9% compared with March 31, 2024.

Cash Position

Cash, cash equivalents and short-term investments as of March 31, 2025 were $21.5 million. Cash decreased by approximately $3.3 million compared with December 31, 2024. Cash used in operating activities was $2.7 million for the first quarter of 2025, compared with $3.2 million used in the first quarter of 2024.

Business Outlook

“While second quarter revenue growth is expected to reflect temporary lead generation challenges experienced early in the first quarter, we continue to expect revenue growth to accelerate in the second half of 2025,” added Mr. Gudonis. “We expect second quarter revenue to be in the range of $9.0 million to $9.5 million. For the full year, we continue to expect revenue to be in the range of $50 million to $53 million, an increase of 54% to 63% compared with 2024,” continued Mr. Gudonis.

Conference Call and Webcast

Myomo will hold a conference call today at 4:30 p.m. Eastern time to discuss these results and answer questions. Participants are encouraged to pre-register for the call at this link. Callers who pre-register will receive a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time up to and after the start of the call. Those unable to pre-register may participate by dialing 844-707-6932 (U.S.) or 412-317-9250 (International). A webcast of the call will also be available at Myomo’s Investor Relations page at http://ir.myomo.com/.

A replay of the webcast will be available beginning approximately one hour after the completion of the live conference call at http://ir.myomo.com/. A dial-in replay of the call will be available until May 21, 2025 at 877-344-7529 (U.S. toll-free), 855-669-9658 (Canada toll-free) or 412-317-0088 (International), with passcode 6665274.

Non-GAAP Financial Measures

Myomo is providing financial information that has not been prepared in accordance with generally accepted accounting principles in the United States, or GAAP. This information includes Adjusted EBITDA. This non-GAAP financial measure is not in accordance with, or an alternative for, GAAP and may be different from similar non-GAAP financial measures used by other companies. Myomo believes the use of this non-GAAP financial measure provides supplementary information for investors to use in evaluating operating performance and in comparing Myomo’s financial measures with other companies in its industry, many of which present similar non-GAAP financial measures. Adjusted EBITDA is EBITDA adjusted for stock-based compensation expense and loss on equity investment. This non-GAAP financial measure is not meant to be considered superior to or a substitute for results of operations prepared in accordance with GAAP, and should be viewed in conjunction with GAAP financial measures. Investors are encouraged to review the reconciliation of this non-GAAP measure to its most directly comparable GAAP financial measure. A reconciliation of GAAP to the non-GAAP financial measures has been provided in the tables included as part of this press release.

About Myomo

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. It is currently the only marketed device in the U.S. that, sensing a patient’s own EMG signals through non-invasive sensors on the arm, can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. Many are able to return to work, live independently and reduce their cost of care. Myomo is headquartered in Burlington, Massachusetts, with sales and clinical professionals across the U.S. and representatives internationally. For more information, please visit www.myomo.com.

Forward-Looking Statements

This press release contains forward-looking statements regarding the Company’s future business expectations, including expectations for second quarter and full year 2025 revenue, which are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are only predictions and may differ materially from actual results due to a variety of factors.

These factors include, among other things:

  • our ability to obtain sufficient reimbursement from third-party payers for our products;
  • our ability to scale the business to return to positive cash flow from operations on a quarterly basis by the fourth quarter of 2025;
  • our revenue concentration with Medicare and with a particular insurance payer as a result of focusing our efforts on patients with insurers who have previously reimbursed for the MyoPro;
  • our ability to continue normal operations and patient interactions without supply chain disruption in order to deliver and fit our custom-fabricated devices;
  • our marketing and commercialization efforts;
  • our dependence upon external sources for the financing of our operations, to the extent that we do not achieve or maintain cash flow breakeven;
  • our ability to obtain and maintain our strategic collaborations and to realize the intended results of such collaborations;
  • our ability to effectively execute our business plan and scale up our operations;
  • our ability to remediate the material weakness in our internal control over financial reporting;
  • our expectations as to our product development programs, including improving our existing products and developing new products;
  • our ability to maintain and grow our reputation and to achieve and maintain the market acceptance of our products;
  • our expectations as to our clinical research program and clinical results;
  • our ability to maintain adequate protection of our intellectual property and to avoid violation of the intellectual property rights of others;
  • our ability to gain and maintain regulatory approvals;
  • our ability to compete and succeed in a highly competitive and evolving industry; and
  • general market, economic, environmental and social factors that may affect the evaluation, fitting, delivery and sale of our products to patients.

More information about these and other factors that potentially could affect our financial results is included in Myomo’s filings with the Securities and Exchange Commission, including those contained in the risk factors section of the Company’s annual report on Form 10-K, quarterly reports on Form 10-Q and other filings with the Commission. The Company cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Although the forward-looking statements in this release of financial information are based on our beliefs, assumptions and expectations, taking into account all information currently available to us, we cannot guarantee future transactions, results, performance, achievements or outcomes. No assurance can be made to any investor by anyone that the expectations reflected in our forward-looking statements will be attained, or that deviations from them will not be material or adverse. The Company disclaims any obligation subsequently to revise any forward-looking statements to reflect events or circumstances after the date of such statements or to reflect the occurrence of anticipated or unanticipated events.

(Tables follow)

MYOMO, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

 

 

For the Three Months Ended

 

 

 

March 31,

 

 

 

2025

 

 

2024

 

Revenue

 

 

 

 

 

 

Product revenue

 

$

9,831,814

 

 

$

3,754,389

 

 

 

 

 

 

 

 

Cost of revenue

 

 

3,222,184

 

 

 

1,455,345

 

Gross profit

 

 

6,609,630

 

 

 

2,299,044

 

Operating expenses:

 

 

 

 

 

 

Research and development

 

 

1,790,024

 

 

 

956,215

 

Selling, clinical and marketing

 

 

4,395,804

 

 

 

2,361,845

 

General and administrative

 

 

3,944,056

 

 

 

2,869,751

 

 

 

 

10,129,884

 

 

 

6,187,811

 

 

 

 

 

 

 

 

Loss from operations

 

 

(3,520,254

)

 

 

(3,888,767

)

 

 

 

 

 

 

 

Other (income) expense, net

 

 

 

 

 

 

Interest income, net

 

 

(191,991

)

 

 

(135,293

)

 

 

 

(191,991

)

 

 

(135,293

)

Loss before income taxes

 

 

(3,328,263

)

 

 

(3,753,474

)

Income tax expense

 

 

136,795

 

 

 

82,158

 

Net loss

 

$

(3,465,058

)

 

$

(3,835,632

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding:

 

 

 

 

 

 

Basic and diluted

 

 

41,454,472

 

 

 

36,752,597

 

Net loss per share attributable to common stockholders

 

 

 

 

 

 

Basic and diluted

 

$

(0.08

)

 

$

(0.10

)

MYOMO, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

 

 

March 31,

 

 

December 31,

 

 

 

2025

 

 

2024

 

 

 

(unaudited)

 

 

 

 

ASSETS

 

 

 

 

 

 

Current Assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

19,793,799

 

 

$

24,372,373

 

Short-term investments

 

 

1,730,460

 

 

 

492,990

 

Accounts receivable, net

 

 

4,663,398

 

 

 

3,825,291

 

Inventories, net

 

 

3,368,502

 

 

 

3,165,965

 

Prepaid expenses and other current assets

 

 

1,541,118

 

 

 

933,377

 

Total Current Assets

 

 

31,097,277

 

 

 

32,789,996

 

Restricted cash

 

 

375,000

 

 

 

375,000

 

Operating lease assets with right of use

 

 

7,295,711

 

 

 

7,584,663

 

Equipment, net

 

 

1,842,254

 

 

 

1,330,008

 

Other assets

 

 

257,085

 

 

 

164,412

 

Total Assets

 

$

40,867,327

 

 

$

42,244,079

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

 

Accounts payable and accrued expenses

 

 

10,448,565

 

 

 

9,021,817

 

Current operating lease liability

 

 

765,616

 

 

 

748,021

 

Income taxes payable

 

 

331,236

 

 

 

318,885

 

Deferred revenue

 

 

129,852

 

 

 

83,115

 

Total Current Liabilities

 

 

11,675,269

 

 

 

10,171,838

 

Non-current operating lease liability

 

 

7,504,994

 

 

 

7,358,184

 

Total Liabilities

 

 

19,180,263

 

 

 

17,530,022

 

Commitments and Contingencies

 

 

 

 

 

 

Stockholders’ Equity:

 

 

 

 

 

 

Preferred stock

 

 

 

 

 

 

Common stock

 

 

3,446

 

 

 

3,439

 

Additional paid-in capital

 

 

128,386,223

 

 

 

127,846,026

 

Accumulated other comprehensive loss

 

 

(116,545

)

 

 

(14,406

)

Accumulated deficit

 

 

(106,579,596

)

 

 

(103,114,538

)

Treasury stock, at cost

 

 

(6,464

)

 

 

(6,464

)

Total Stockholders’ Equity

 

 

21,687,064

 

 

 

24,714,057

 

Total Liabilities and Stockholders’ Equity

 

$

40,867,327

 

 

$

42,244,079

 

MYOMO, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Three Months Ended March 31,

 

2025

 

 

2024

 

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

 

 

 

 

Net loss

 

$

(3,465,058

)

 

$

(3,835,632

)

Adjustments to reconcile net loss to net cash used in operations:

 

 

 

 

 

 

Depreciation

 

 

158,442

 

 

 

29,685

 

Stock-based compensation

 

 

540,204

 

 

 

320,288

 

Accretion of discount on short-term investments

 

 

(11,747

)

 

 

(49,053

)

Bad debt expense

 

 

51,643

 

 

 

 

Amortization of right-of-use assets

 

 

288,951

 

 

 

58,658

 

Amortization of deferred offering cost

 

 

29,039

 

 

 

 

Other non-cash charges

 

 

(34,171

)

 

 

63,930

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

Accounts receivable

 

 

(637,054

)

 

 

718,676

 

Inventories

 

 

(550,772

)

 

 

(597,087

)

Prepaid expenses and other current assets

 

 

(628,186

)

 

 

6,897

 

Other assets

 

 

(70,210

)

 

 

 

Accounts payable and accrued expenses

 

 

1,440,877

 

 

 

87,041

 

Operating lease liabilities

 

 

164,405

 

 

 

(115,191

)

Deferred revenue

 

 

46,738

 

 

 

(11,181

)

Income taxes payable

 

 

 

 

 

77,405

 

Net cash used in operating activities

 

 

(2,676,899

)

 

 

(3,245,564

)

CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES

 

 

(1,896,098

)

 

 

(3,542,565

)

CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES

 

 

(36,506

)

 

 

5,361,909

 

Effect of foreign exchange rate changes on cash

 

 

30,929

 

 

 

(10,360

)

 

 

 

 

 

 

 

Net increase in cash, cash equivalents and restricted cash

 

 

(4,578,574

)

 

 

(1,436,580

)

 

 

 

 

 

 

 

Cash, cash equivalents and restricted cash, beginning of period

 

 

24,747,373

 

 

 

6,871,306

 

 

 

 

 

 

 

 

Cash, cash equivalents and restricted cash, end of period

 

$

20,168,799

 

 

$

5,434,726

 

MYOMO, INC.

RECONCILIATION OF GAAP NET LOSS TO ADJUSTED EBITDA

(unaudited)

 

 

For the Three Months

Ended March 31,

 

 

 

2025

 

 

2024

 

GAAP net loss

 

$

(3,465,058

)

 

$

(3,835,632

)

Adjustments to reconcile to Adjusted EBITDA:

 

 

 

 

 

 

Interest income, net

 

 

(191,991

)

 

 

(135,293

)

Depreciation expense

 

 

158,442

 

 

 

29,685

 

Stock-based compensation

 

 

540,204

 

 

 

320,288

 

Income tax expense

 

 

136,795

 

 

 

82,158

 

Adjusted EBITDA

 

$

(2,821,608

)

 

$

(3,538,794

)

 

Myomo:

[email protected]

Alliance Advisors IR:

Tirth T. Patel

[email protected]

212-201-6614

KEYWORDS: United States North America Massachusetts

INDUSTRY KEYWORDS: General Health Health Medical Devices

MEDIA:

Logo
Logo

Brady Corporation Announces Earnings Conference Call

MILWAUKEE, May 07, 2025 (GLOBE NEWSWIRE) — Brady Corporation (NYSE: BRC), will announce its fiscal 2025 third quarter financial results on Friday, May 16, 2025.  

A conference call will be held beginning at 10:30 a.m. Eastern Time (9:30 a.m. Central Time) Friday, May 16, 2025. Participants will be able to access the webcast and presentation here live and in replay.

This call is being webcast by Notified and can be accessed here.

About BRC

Brady Corporation is an international manufacturer and marketer of complete solutions that identify and protect people, products and places. Brady’s products help customers increase safety, security, productivity and performance and include high-performance labels, signs, safety devices, printing systems and software. Founded in 1914, the Company has a diverse customer base in electronics, telecommunications, manufacturing, electrical, construction, medical, aerospace and a variety of other industries. Brady is headquartered in Milwaukee, Wisconsin and as of July 31, 2024, employed approximately 5,700 people in its worldwide businesses. Brady’s fiscal 2024 sales were approximately $1.34 billion. Brady stock trades on the New York Stock Exchange under the symbol BRC. More information is available on the Internet at www.bradycorp.com.

For More Information:

Investor contact: Ann Thornton 414-438-6887
Media contact: Kate Venne 414-358-5176